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Different regulatory processes 
affecting cells
Physical and biochemical interactions with the direct environment around a cell 
can affect its gene expression3 and have been shown to influence differentiation. 
Control signals from outside the cell use signal transduction cascades within the 
cell to reach the DNA. Such regulation pathways depend on all proteins involved 
in each specific signal transduction pathway. There may be different routes leading 
to a similar change in the gene expression, or different gene expressions leading to 
similar cellular behavior. The presence of proteins involved in signal transduction 
pathways is crucial, hence the efficiency of the pathway also depends on the (previ-
ous) state of a cell. The current state of a cell and its history have for this reason 
a great effect on the cellular response to regulatory stimuli. 
It is clear that the micro-environment around cells plays an important role in bio-
logical experiments. Zooming in on cells in an organism, we can distinguish many 
different micro-environments. Some cells are floating in a suspension (e.g. white 
blood cells), some cells form contact with an extracellular matrix (ECM) or with 
other cells (e.g. liver or nerve cells). The ECM is a matrix of polysaccharides and 
fibrous proteins, the exact composition and structure determines its rigidity and 
regulatory properties. It is a challenge to find and mimic these properties in vitro, 
a detailed comparison study of tissue engineered and native heart valves by K. 
Schenke-Layland is given as example4.
Next to the ‘passive’ micro-environment there are many different specific active 
biological regulatory signals interacting with cells. Hormones or proteins can bind 
to membrane associated receptor proteins, causing a conformational change and 
inducing a signal cascade eventually leading to gene regulation5. Similar processes 
can be induced by direct cell-cell interactions. Cells can also release small vesicles 
containing proteins and/or RNA6. These vesicles can then bind to and be incor-
porated into the outer membrane of other cells, thereby releasing the content in 
their cytoplasm. Many types of vesicles were discovered, see Figure 1.1, and for 
many, their exact function is still unknown7.
 Bacteria and viruses use cells and their protein production machinery to spread 
and proliferate. Organisms have special defense mechanisms to combat such dis-
eases, but fast evolution of the disease agents allow them to quickly adapt. Viruses 
Abstract
Higher organisms are made of cells that must collaborate for the organism to 
thrive. In multi-cellular organisms, cells are controlled by regulatory processes. 
Regulation of a cell is a complex process involving many types of interactions. 
To study regulatory processes, cells have to be grown and stimulated in a 
controlled way, because a cellular response to external stimuli depends on 
the internal state of a cell. The accuracy of the study depends on the ability to 
mimic the in-vivo situation, in which cells are exposed to complex and changing 
environments. However, cells grown in a more complex and changing environ-
ment can display a larger variance in behavior. Therefore high-throughput ex-
perimentation is required to gain sufficient statistical power.
 In this thesis, four new research methods for investigating cell regulatory 
processes are presented. The design methodology used to create these meth-
ods is introduced at the end of this chapter.
Introduction
Cells form the basis of life as we know it. Although there are many different 
types of cells, and many different species, the cell’s chemical factory is a highly 
conserved machinery, similar among many different species and types of cells. 
In an organism, most cells share the same DNA sequence, which encodes 
the amino acid sequence for all the proteins and RNAs that the organism can 
make. Regulatory proteins that reside close to the DNA interact specifically 
with individual coding sequences on the genome. Proteins and DNA folding 
tightly control the gene expressing in a cell1. Cell types can have different 





and cells can start to divide and grow uncontrollably13. Subsequent activation of 
other regulatory processes can lead to growth of new blood vessels toward the 
tumor site, or migration of tumor cells towards new sites. Lack of nutrition causes 
oxidative stress, by which cells surrounding the tumor (and within the tumor) die. 
The cellular components can then be recycled by (tumor) cells. Through paracrine 
(local) cell-cell signaling the surrounding tissue plays an active role in cancer initia-
tion, growth and possible spread14.
Cancer tumor growth influences therapy strategies. Depending on the cell type, 
derailed cells form different cancer cell types, which may show different growth, 
migration and proliferation. It is believed that the micro-environment (Fig. 1.3) 
during tumor growth can initiate further differentiation into multiple different can-
cer cell types. Some cancer cells may be more involved in migration whereas others 
may be more involved in proliferation15.
enter the cells with RNA or DNA and use the cell’s own machinery to create 
new virus particles9. Most bacteria do not harm, but for instance help digestion 
processes, hence the perhaps somewhat surprising observation that a human or-
ganism contains more bacteria than cells. However, some bacteria are using hu-
man cells to proliferate, divide and spread uncontrollably10. Such disease causing 
bacteria are normally recognized by the defense mechanism of the organism and 
taken care of by macrophages. Within macrophages the phagocytosis pathway 
uses special enzymes to break down the bacteria. However, some bacteria, such 
as those causing tuberculosis, have a defense mechanism against phagocytosis and 
hijack the macrophages to proliferate at cost of the host organism (Fig. 1.2).
 In cancer, the mutated cells of the organism itself form a threat to life. Disease 
can occur when cells are transformed such that the gene regulation limiting cel-
lular growth is altered beyond repair12. Normally, such changes would result in cell 
death, however, in cancer cells also the death regulatory pathways are disrupted, 
Figure 1.2 Using zebrafish as a model organism. Davis and Ramakrishnan demonstrated that 
growth of Mycobacterium marinum in the phagocyte (the zebrafish equivalent of the human mac-
rophage) eventually leads to cell death. New bacterium niches (granulomas) are formed when 
infected cells recruit uninfected cells.
From Eric J. Rubin, The new england journal of medicine 2009 [11]
Figure 1.1 Different processes known to produce micro-vesicles. Based on the origin, vesicles can 
be characterized on their content and/or membrane composition (shell), based on proteins resid-
ing in the shell, or the physical composition, i.e. the number of lipid-layers. The depicted processes 
of producing vesicles are not yet completely understood.




Studying cell regulatory processes
In medicine, during diagnosis, the cellular resolution shown in the above ex-
amples is not available without taking biopsies. As a result, from diseases with a 
cause at the cellular level or smaller, mostly only indirect measurements can be 
made, which are not always accurate. For example, to measure the recent pand-
emie fluenza virus infection (2009), the only rapid assays which were available 
had poor clinical sensitivity (11 to 70%) and could not detect a specific influenza 
A subtype17. Indications of pain, fever or visible abnormalities are results of 
(disease with) complex regulatory processes, that are difficult to relate directly 
to cellular disorders. Multiple steps, multiple diagnostic tests and sometimes 
multiple treatments are used to characterize the cellular origin18. 
Fortunately, many disease interactions with(in) the organism create specific by-
products, such as raised protein levels in blood or urine, which sometimes can be 
measured. Blood tests are more and more focused on the detection of these spe-
cific biomarkers19, 20, known to be associated with specific diseases. To understand 
and find a specific biomarker, the precise disease mechanisms have to be unrav-
eled. Next to bulk measurements aimed at finding direct correlations (large scale 
diagnostic testing), this is done using in-vitro and in-vivo experiments that result in 
a deeper insight into the complex disease and host mechanisms such that specific 
biomarkers or possible targets for drug interaction can be found21.
The interplay between cell migration, cell stress and ex-
ternal forces.C
Cancer cells can migrate in an organism, thereby spreading the disease. One of 
the regulatory pathways in cancer cell migration is the cell adhesion kinetics path-
way22. Cell adhesion is intensified when forces acts on a cell23. In vitro this has been 
shown by stretching a deformable cell support, and by subjecting cells grown in 
a layer to shearing forces using a fluid flow. Currently, study of this type of cell 
stress requires dedicated microfluidic systems, that are complex to use24. 
 In chapter 2 a simpler system is introduced that could be used to study cell 
adhesion kinetics in detail using bright-field, phase-contrast, DIC and confocal 
fluorescence microscopy.
Figure 1.3 The in-vivo environment of tumor cells. The blood vessel is the source of nutrients, 
and of most therapeutics. The nutrient gradient that forms as a result of diffusion is the cause 
of necrosis of distant cells. However, the gradient of therapeutics may explain the resistance to 
therapy, as the dose for more distant tumor cells may not reach the required level, or may be less 
active due to a hypoxic, acidic or nutrient deprived environment. The correlation to the location 
with respect to the blood vessel can be clearly seen. In (a) cervix cancer around a blood vessel, 
and in (b) a xenograft of colon cancer around a blood vessel. Black staining shows proliferating 
tumor cells. Green staining indicates hypoxic regions. Endothelial cells are colored blue. In (c) a 
schematic overview.




Inhibiting cell migration in 3D
Tumor cell migration is often studied in-vitro in regular monolayer cell culture. 
Hanging drop assays (Fig. 1.4A) have shown to be valuable in better mimick-
ing the in-vivo situation by creating a small tumor of cancer cells in a 3D gel. 
Confocal imaging and compound testing have shown that cells grown in 3D re-
spond differently to drugs than cells grown on a plate. Hanging drop assays and 
similar techniques of growing a clump of cells first, followed by embedding in a 
gel are difficult to perform reproducibly and time consuming. A clump of cells 
can be formed using many different methods, for an overview, see Figure 1.4.
Do blood plasma microparticle numbers associate with 
disease?
In certain diseases it has been found that the amount of blood plasma micropar-
ticles was increased. It could be that these microparticles are actively involved in 
disease processes or are by-products of other regulatory processes25. Currently, 
there is no convenient method for determining the accurate number, origin and 
size of microparticles. It has been shown that Atomic Force Microscopy (AFM) 
can be used to determine size and number of anti body bound microparticles on 
a mica surface26. However, this method involves many treatment and purifica-
tion steps, which may be affected by systematic errors. 
 In chapter 3 an improvement in the capture of microparticles on an antibody-
coated surface is introduced, which removes the need of ultra-centrifugation, 
reducing the chance of systematic errors and the time before measurement.
Can we effectively test potential tuberculosis drugs in ze-
brafish embryos?
In diseases caused by bacterial infections it is difficult to investigate the regulatory 
processes and spread of the disease as they occur inside the organism. In human 
imaging, bacteria are too small to see, and therefore small test animals are used 
to study bacterial infections in detail. Tuberculosis (TB) is a disease caused by My-
cobacterium tuberculosis in humans27. Antibiotics are used to treat the disease, but 
increased resistance against many antibiotics is cause for global concern28.
 Currently guinea pigs offer the best similar disease symptoms, but are un-
fortunately also difficult to image and study. Therefore, another similar bacte-
rium is used, Mycobacterium marinum, which allows studying the progression in 
zebrafish embryos. Many of the TB regulatory processes have been unraveled 
using this zebrafish model, and significant progress can be anticipated when 
a high throughput system is developed to use zebrafish in faster compound 
screening to find new drugs. 
 
In chapter 4 a new high throughput system for the infection of zebrafish 
embryos with (TB) bacteria is introduced which can be used for compound 
screening. Surprisingly11, we discovered that zebrafish can also be infected 
with the human Mycobacterium tuberculosis (MTB).
Figure 1.4 Different methods to create multicellular spheroids. In (A) using hanging drops, in 
(B) using a nonadhesive surface, in (C) using micromolds, in (D) using Spinner flasks, in (E) using 
Rotary cell culture, in (F) using self assembly of Hepatocytes on Primaria dishes, in (G) using 
porous 3-D scaffolds, in (H) using PNIPAAm-based cell sheets, in (I) using cell-pellet culture, in 
(J) using cellular aggregation originating from Electric, magnetic or acoustic forces, in (K) using a 
mixture of single cells with gel. Epithelial cysts are shown in (L)




Chapter 3. Determination of the size distribution of blood 
microparticles directly in plasma using atomic force micro-
scopy and microfluidics
Problem: The concentration of blood plasma microparticles caught on an 
antibody coated mica surface is too low to measure conveniently using AFM.
Solution: Using a detachable microfluidic channel the same amount of fluid is 
run over a smaller surface area resulting in a higher number of microparticles 
attaching to the surface.
Chapter 4.  A high-throughput screen for tuberculosis 
progression
Problem: Manual injecting zebrafish embryos is time consuming and prone 
to human errors, current automated methods do not scale well.
Solution: A better method of aligning zebrafish eggs has been invented by us-
ing a grid of hemispherical holes in agarose gel. The agarose gel allows optimal 
viewing from below, such that injection can performed vertically, and calibra-
tion of the injection depth is achieved by looking at the deformation of the 
embryo in the plane perpendicular to the optical axis.
Chapter 5. Automated microinjection of cell-polymer 
suspensions in 3D ECM scaffolds for high throughput quan-
titative cancer invasion screens
Problem: Current methods to disperse and monitor cells in 3D are slow and 
difficult to automate.
Solution: Cells are injected into the gel directly, mixing the cells with poly-
mers allows the formation of a compact droplet, in which cell-cell contacts 
are formed within a day. Automation of injection allows for high-throughput 
injection and imaging.
Depending on the cell type it can take up to two weeks for forming a tumor 
with migrating cells. Cells that do not form cell-cell contacts are not suited for 
hanging drop assays. In chapter 5 it is shown that injection of a cell suspension 
into a gel can be used as well to form tumor spheroids similar to those derived 
from hanging drops. However, the method of injection can be automated and 
is shown to be usable in high-throughput in-vitro tumor migration assays to find 
new drug compounds. Possibly, this enables personalized treatment based on 
screen results derived from a patient’s own biopsy.
Design aspects of this thesis
This thesis describes novel experimental methods and protocols aimed at study-
ing cells and fragments of cells in a controlled, high throughput fashion. To invent 
or refine protocols a common design theory was used, introduced in this chap-
ter’s supplement. In short, the design theory allows the researcher to extract all 
elementary operations from a protocol or from methods used in a protocol. In 
an existing protocol, these elementary operations are performed using a previ-
ously chosen solution. To improve the method or protocol, i.e. to enable better, 
faster or more reliable experimentation, one can look at the performance of 
each of these solutions. Using the operation criteria of individual solutions one 
can even look for new/other possible solutions, which might improve the overall 
performance or the research method. The impact of such an improvement can 
be predicted and eventually measured during experimentation. For all research 
projects the improvements with the highest impact are listed below.
Chapter 2.  A versatile microfluidic flow cell for studying 
the dynamics of shear-stress induced actin reorganization 
in renal cells
Problem: microfluidic chips are complex in use, and require dedicated mi-
croscopes or holder systems.
Solution: Using a method of piercing a capillary tube into the side of a PDMS 
microfluidic chip, a fluid side connection can be established. Such a side con-
nection leaves enough room for all types of optics devices above and below 
the chip. A microfluidic channel in PDMS fitted with in- and outlet tubes offers 
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a protocol, nor the possible outcomes in case errors occur. The new journal 
“Nature Protocols” offers a good practice of mentioning common pitfalls and 
control measurements to check if a protocol works as designed.
A key step in engineering (new) methods is to create a list of functions, acting 
on the sample, in a logical chain, similar to a protocol, where a list of actions is 
described. Each action is performed using a specific tool or instrument; it is in 
essence the solution to the function that was required. The tool or instrument 
to perform the action is chosen based on specific requirements, performance, 
availability and costs.
When multiple (parts of) protocols can be used resulting in a similar measure-
ment or specimen outcome, there exists one list of functions describing both 
protocols, here called the golden list of functions (GLF). For example, for the 
function “separate cells from a suspension”, there are two (probably more) 
lists of possible actions (solutions):
 1. pipette cell suspension onto a 1-micron filter, resuspend filtered cells 
 using a pipette
 2. fill a tube with the cell suspension, centrifuge at 500 g for 5 minutes, 
 resuspend the cell pellet using a pipette
Each solution can have its own benefits and costs, and required instruments. 
Clearly in the above example a pipette is a necessity, i.e. when a pipette is not 
available another solution must be found. The first solution uses (disposable) 
filters, that can be expensive when a lot of cells have to be separated, while the 
second requires a centrifuge, which may be cheaper in the long run.
To allow for a fair method comparison the GLF must be found first. Note that 
this practice is often omitted in review articles, and this correlates strongly with 
a reduction in the objectivity of the author towards the different methods. 
 Similarly, when one likes to improve an existing protocol it is wise to con-
struct a list of functions first, as this allows for an overview of all functional-
ities. Sometimes it might be possible to integrate one or more functions into 
a new function. This can also help in finding the GLF, which can be explained 
using the same example as described above, take action list 1, translated to 
functions:
 F1: transfer cell suspension onto filter device results in filtered cells 




Changing protocols, method development
It is known that the change of habitat of cells, taken from a multi-cellular or-
ganism, to single cell species culture has a large impact on the cell fate. This 
effect is significant: some cell types are very difficult to keep alive outside the 
organism. Studies of cells outside the organism may require the development 
of new methods that have to be tested and shown to be biologically relevant.
 The state of the biological specimen must either be very close to the state 
in other comparable experiments, or else experiments must be performed to 
show that the treatment of the specimen does not alter the specimen’s state so 
much that the results have only little predictive value. Next to the fact that there 
must not be more than a single variable changed between control and wild-type 
experiments, to be able to address the difference in results to this single varia-
tion, the experimental setup itself must also be tested. This is explained in more 
detail in Chapter 6.
 Keeping in mind that biological material is more difficult to control, and 
often needs inspection using microscopy, the design methodology of new 
methods and systems for experimentation is similar to methodologies used in 
standard engineering. The complexity of biological material however, requires 
discussions between biologists, chemists, physicists and engineers. Literature, 
experience and other sources of information are used as a source for methods 
and protocols, which are not always accessible for specialists from other, col-
laborating fields. 
 A common design concept and language help to lower the language barri-
ers between people from different fields and guides the design towards system 
requirements and specifications. In this thesis work standard design principles 
were used as described in the book “Fundamentals of business engineering and 
management”1. A short introduction of design principles used in this thesis is 
given below.
Engineering protocols
A cell-biology protocol consists of one or more steps of sample treatment 
and one or more different measurements. Each of these steps is performed 




Discussions with many people, from different disciplines, including mechanical 
engineers allowed me to find new solutions for specific functions required in 
existing protocols. Key element in this research was to translate the proto-
cols into the exactly needed functions, and through many discussions find out 
what requirements of each function are. Within the Cell Observatory many 
different research groups are located at close proximity, enabling easy com-
munication and discussions. Thus it provided the stimulating, multi-disciplinary 
environment that is required for the type of work described in this thesis.
Figure 1.5 Detail from Figure 3, Wenhui Wang, Xinyu Liu, Danielle Gelinas, Brian Ciruna and 
Yu Sun, PloS ONE, 2007[2]
We can ask the question “for what purpose?”, and the answer is as given: “to 
separate cells from a suspension”. As such the chain of functions is shortened, 
and one could check if other (parts of) protocols follow the same chain. Even 
from this simple example it can be seen that the exact answers are not always 
obvious. Another answer to the question above could be “to increase the cell 
concentration” or “to remove proteins from the cell suspension”.
To find solutions to given functions, the GLF can be used to generate more - 
and more detailed - chains of functions. Often it is possible to find many chains 
of elementary functions that describe a higher function, i.e. a less precise func-
tion described at a higher level of abstraction. It’s left for the reader to create 
a chain of elementary functions of the second list of actions of the above ex-
ample, to result in two chains of elementary functions that describe “separate 
cells from a suspension”.
Creating a new protocol or improving an existing protocol is challenging and 
requires many design decisions. Using the GLF it is easier to see how improve-
ments in one function might influence the performance and or necessity of 
others. It also allows insight to combine parts of existing protocols, or to 
search for more solutions for one given function. In this thesis in each article 
mostly one fundamental function was changed, for example “align zebrafish 
eggs” in Chapter 4, leading to vast improvements in performance of others.
As an example, a previous solution to align zebrafish eggs was to partly suck 
the eggs into tiny holes in a plate (Fig. 1.5). The article described the success-
ful, advanced method of automatic alignment procedures that were designed 
to enable fast, automated injections of 25 eggs per run of 2 minutes, using this 
alignment plate.
 From the image in the article, it can already be seen that alignment was not 
perfect and centered, and therefore required image recognition before each 
injection. Also it was difficult to scale this design up, as suction of a 1000 eggs 
on a plate is physically very difficult (eggs rupture because of the required 
higher suction pressure). As such we choose to search for a better alignment 
solution (see Chapter 4).
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of PTCs remains poorly understood6,7. Until now, only two studies on PTCs 
showed that these cells undergo a change in phenotype in response to FSS and 
that there is a marked redistribution of F-actin8-11. Nevertheless, these studies 
were limited to fixed samples and could not provide spatiotemporal informa-
tion on FSS-induced renal cell cytoskeletal reorganization. 
 The best known device to study FSS on adherent cells is a parallel plate 
chamber12. Using such a device, cells are first grown on a coverslip, and then 
the flow cell is constructed around this coverslip before the flow experiment 
is performed. This method has several disadvantages. During the construction, 
prior to the experiment, the cells are subjected to pressure changes and me-
dium flows which are unpredictable and not reproducible. Once assembled, 
most flow cells, including the parallel plate chamber, are difficult to move, and 
therefore placed on the microscope for the duration of the experiment. Con-
trol experiments, using the same flow cell but without flow or with minimal 
flow, are for this reason performed at different time-points or locations. 
 
The use of multiple microfluidic channels instead of one large parallel chamber 
would offer an adapted solution. For this reason we searched for a micro-
fluidic chip platform that does not need to be assembled directly onto the 
microscope. Furthermore it should be compatible with many types of light mi-
croscope setups. Using the gas-permeable properties of polydimethylsiloxane 
(PDMS), we found that a passive medium flow is sufficient to culture cells for 
weeks in microfluidic channels, allowing us to create a mobile and flexible us-
age of the microfluidic cell culture platform. When connected to small medium 
containing flasks, the microfluidic culture system is compatible with standard 
cell incubators. Furthermore, a novel side connection to thin glass capillary 
tubes allowed us to conform to the working distances of both condenser and 
objective lenses used in high resolution fluorescent light microscopy. In con-
clusion, we designed a multishear microfluidic device that allows controlled 
fluidic shear stress on cells in parallel and that is suitable for high resolution 
light microscopy. This is particularly beneficial for studying the actin cytoskel-
eton reorganization upon shear stress, as it is demonstrated in this paper.
 Following the introduction of the chip, we present the effects of FSS on 
renal tubular epithelial cells. We exposed LLC-PK1 cells expressing ectopi-
cally either GFP-actin or GFP-zyxin to a defined laminar flow in a parallel flow 
chamber and performed live cell imaging of the actin cytoskeleton re-organi-
zation. LLC-PK1 cells express the phenotype of epithelial cells of the proximal 
Abstract
To resolve spatially and temporally the dynamics of the actin cytoskeleton 
under shear-stress, we developed a microfluidic flow cell featuring multiple 
channels. Using novel side connections, the microfluidic device is suitable for 
various light microscopy techniques in combination with high resolution imag-
ing. In this device, different types of cells can be cultured for weeks without 
active flow control in a standard cell incubator. We evaluated shear-induced 
reorganization of the actin cytoskeleton of renal LLC-PK1 cells expressing 
ectopic GFP-actin. Using this device, we subjected the cells to a laminar flow 
and quantified in time and space the change in phenotype between control and 
shear situation. During the time of the experiment, we observed that a laminar 
flow induces enhanced cell motility associated first with lamellipodia forma-
tion, followed by actin stress fibres formation together with a reinforcement of 
the cortical ring. These results demonstrate the versatility of our newly devel-
oped microfluidic flow cell that fits with any standard microscope and indicate 
that enhanced local tubular flow-mediated shear forces affect the intracellular 
signalling that drive cytoskeletal reorganization.
Introduction
In the kidney, renal tubular cells are continuously bathed by the tubular fluid. 
The tubular flow is a main determinant of kidney behaviour in term of trans-
port of water and solutes. Fluid shear stress (FSS) produced by this renal 
tubular flow is a modulator of salt and water reabsorption. An intact actin 
cytoskeleton is essential for proximal tubular cells (PTCs) to transmit flow-
induced mechanical forces and subsequently modulate transport. The tubular 
flow rate, relatively stable in physiological conditions, may increase after a 
substantial reduction of renal mass. As a consequence, one of the hallmarks 
of renal mass reduction is still the progressive deterioration of the remain-
ing functional nephrons which may be partly caused by flow-induced pheno-
typic modification of proximal tubular cells (PTCs). This deterioration of renal 
structures is observed in a large number of renal diseases1. In contrast to 
vascular endothelial cells (Ecs)2-5 the effect of FSS on cytoskeletal organization 
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A mould used to create a microfluidic flow cell was fabricated using CNC 
milling a structure, designed in autocad, out of brass. To be able to create an 
optically flat surface of the channel, the mould was created in four steps, as 
illustrated in Fig. 2.2 (a-d). First the structure of the circuit is milled out of 
brass(a), and at the edges of the structure at the same level as the top of the 
dykes in the structure sacrificial material was maintained. The sacrificial mate-
rial was used to support the polishing tool, to be able to polish (b) the surface 
of the top of the dykes. After polishing this sacrificial material was removed. 
Then, from the bottom little holes are drilled towards the end of the channels, 
the location of the receiving chambers (c). Finally pins with a diameter of 0.5 
tubule and have previously been described to be sensitive to fluid shear stress 
(FSS)10. We have quantified fluid shear stress (FSS)-induced actin cytoskeleton 
reorganization in time and space. The results show that renal cells respond to 
FSS with an increase in motility associated with a cytoskeletal reorganization 
including lamellipodia and cytosolic actin filaments formation together with a 
reinforcement of the lateral actin network.
Material and Methods
Microfluidic flow cel
To understand in more detail how cells change their phenotype when exposed 
to laminar flow, we developed a microfluidic flow cell which comprises three 
channels, allowing for a direct comparison between shear stressand control 
environment. The PDMS channels are produced using a mould which was fab-
ricated from brass using standard milling techniques.
 The flow cell is constructed in a novel way, by injecting bevelled glass capil-
lary tubes from the side into the PDMS chip (Sup. Mov. 1). After injecting the 
glass capillary tube to form in- and outlet, the connections are fixed and the 
tubes stay attached for the duration of the experiment (Fig. 2.1(a), 2.1(e)). 
With these side-connections the condenser lens has freedom to operate, and 
can be positioned close to the top of the device. After the flow cell is loaded 
with cells, it is connected to small reservoirs containing fresh medium (Fig. 
2.1(b)). The reservoirs are placed slightly above the flow cell, to allow for 
passive flow of fresh medium to the microfluidic channels, as the medium 
evaporates slowly through the PDMS. The resulting device is small and stable 
enough to move easily from incubator to a microscope. Prior to applying shear 
stress, the cells are grown for a couple of days to the desired confluence.
Preparation of capillaries
Capillary tubes having an outer diameter of 375 micrometer and an inner diameter 
of 150 micrometer (TSP Fused Silica Tubing, deactivated with DPTMDS, from 
BGB-shop) are cut using a piece of aluminum oxide to create a slight scratch in 
the glass, through the polyimide coating. The capillary ends are bevelled using 
mechanical grinding with a disc containing diamond dust. Before and after the me-
chanical grinding, the capillaries are rinsed with MilliQ water to remove glass dust.
Figure 2.1 Overview of the use of the flow cell for live cell imaging. In a, flow cell is prepared 
and adherent cells are brough into suspension. In b, using little vials and a syringe to create 
a pressure, the flow cell is loaded with cells. When cells are loaded, vials containing medium 
are connected, and the flow cell is placed in the incubator (c) to stimulate cell growth. When 
cells reach enough confluence, a flow cell is selected and placed in a temperature controlled 
microscope. One or two channels are connected to the pumping system to apply a shearing 
force to the cells (d). In (e), a picture of a flow cell, fabricated on a microscope glass. (f) shows 
a connected flow cell as placed in the incubator.
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oxygen plasma for 30 seconds. Then within a couple of minutes both parts are 
pressed and held together and placed in an oven at 70 degrees Celsius for one 
hour. On the top side of the PDMS a standard microscope glass is adhered to ease 
transport and to place the flow cell in a standard microscope setup. After connec-
tion (i), an extra layer of PDMS is applied (j). This extra layer provides a stronger 
bond between the bottom glass plate and the PDMS. Before or after connecting 
the flow cell, depending on the experiment, the flow cell and capillaries are steril-
ized using an autoclave at 120 degrees Celsius for 30 minutes (k).
Fluid manipulation in the microfluidic flow cell
Autoclaved flow cells were connected to little septum capped vials (1.5 mL, 
Grace Alltech) and filled through capillary tubing. After the inlet and outlet of 
the flow cells were each connected to a vial, a slight overpressure was gener-
ated by injecting a syringe needle into a closed vial and injecting clean air. This 
pressure generates a flow of liquid from the vial through the submerged entry 
capillary connected to the flow cell and the exit capillaries to the exit (waste) 
vial. This method was used to rinse, prepare and fill the microfluidic flow cell.
Medium Flow
Using One-Piece Fittings from LabSmith (http://www.labsmith.com) the inlet 
capillaries were connected to micro-angular gear pumps (mzr2521 and mzr-
controller, HNP Mikrosysteme GmbH, Germany) and the outlets of the chan-
nels were let to a waste reservoir. The pump was operated at 60 percent 
of the max speed, and used to pump at a flow rate of 1 mL/hour, through a 
channel (w/h=300μm/100μm) resulting in a mild shear stress of approx 6 dyn/
cm2 . Formula (1) is used to calculate shear stress assuming parallel plate ge-
ometry13.
 
	 	 	 	 	 	 		τ	=
Formula (1)
Q = flow rate in cm3/s ( 3·10-4 cm3/s), μ = viscosity (ca. 0.01 dyn s/cm2), h = 
channel height (0.01 cm), b = channel width (0.03 cm), τ = wall shear stress 
(dyn/cm2), calculated to be ~6 dyn/cm2 (6·10-5 N/cm2).
mm are inserted in these holes and mounted at a height of preferably half the 
height of the flow cell plus half the diameter of the tubes used to connect the 
flow cell, these pins will form the receiving chambers (d).
 The mould is filled with a mixture of degassed PDMS (Dow Corning Sylgard 
184, mixed in a 10:1 ratio), see Fig. 2.2(e). A vacuum is applied to degas the 
PDMS mixture until all entrapped air is released (takes about 30-60 min). The filled 
mould is carefully covered (to reduce the chance of reintroducing air bubbles) 
with a glass plate to create an optically flat surface (f). Curing is performed at 70 
degrees Celsius for one hour. The brass mould is removed (g) and an oxygen 
plasma treatment (Femto, Diener Electronic) is used to covalently bind a cover 
slide onto the freshly cured polymer flow cell to form the bottom of the micro-
fluidic device (h). For this the glass cover slide is first placed in the oxygen plasma 
(standard air, 0.1 mbar) for 10 min, after the PDMS part is placed under the same 
Figure 2.2 Schematic overview of the mould fabrication process. First the channel struc-
ture is milled in brass (1; a), followed by polishing of the channels (2; b). After, the polishing support 
(3) is removed using milling, and holes are drilled (4) through the mould at the place of the con-
nection chambers (c). Rods are placed in the holes (6), and mounted to the desired height (d). A 
ring(5) is used to support the glass (8) during polymerization of the PDMS (7; e, f). After, the flow 
cell is removed, cut to the desired size, and placed onto a microscope glass (8; g). Using an oxygen 
plasma treatment, a coverslip (10) is covalently bound to the PDMS (h). Then the closed flow cell 
is injected using beveled glass capillary tubes(11) until the connection chambers (9) are reached (i). 
Finally, extra PDMS is poured over the glass slide and the capillary tubes, to secure the connection 
(12; j). Before use, the flow cell is sterilized using an autoclave (k).
6Qμ
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During shear stress experiments cells were visualized during 24 hours with a 
confocal Nikon TE 2000-E microscope equipped with perfect focus system in a 
humid climate of 37°C and 5% CO2. A z-scan was done through the cells to be 
able to visualize both F-actin stress fibres and cell-cell contact (8 scans every 
1,5 μm so in total 12 μm ). Movie frames were captured every 10 minutes us-
ing a 20x objective for 12 hours.
Nomarski (DIC) imaging, TIRF imaging
The TIRF and DIC pictures were captured on a Nikon TIRF microscope sys-
tem (Eclipse Ti-2000, Nikon with automated stage) using a 60x plan apo TIRF 
NA 1.49 lens objective and controlled by NIS-elements AR software (Nikon). 
 Differential interference contrast (DIC or Nomarski) imaging uses polar-
ized light and selectively captures polarization changes after a second polariza-
tion filter used to remove the input light. These polarization changes provide 
detailed information about the cellular shapes and structure.
Image analysis
Manual cell tracking and image processing and some analysis were done using 
Image-Pro Plus (version 7.1, Media Cybernetics Inc., Silver Spring, MD) while 
others were done using the free software ImageJ (NIH). For the analysis of the 
confocal movies, we used the extended depth of focus. This method combines a 
Z-stack and results in a single composite best-focus image. For this, the Z-stack 
was combined with the maximum through depth contrast. Then, the mean value 
of the pixels from each plane at the current location is calculated. Finally, the 
pixel from the plane with the largest variance from the mean is selected.
Results
To test the compatibility of the microfluidic device for cell culture, we used 
three different cell types including human tumor HeLa cells, keratinocytes 
(data not shown) and renal epithelial LLC-PK1 cells (Fig. 2.3). 
 The PK1 cells were cultured inside the channels for up to three weeks and 
showed a multilayer structure as is the case as well in a basic culture flask 
(Fig. 2.3(a)). After two days of incubation in a channel, a group of cells is im-
Cell culture
The porcine renal epithelial cell line (LLC-PK1) cells were maintained in 
DMEM supplemented with 10% (v/v) fetal calf serum and penicillin/strepto-
mycin at 37°C in a humidified atmosphere of 95% air and 5% carbon dioxide. 
For preparation of stable GFP-actin expressing cell lines, LLC-PK1 cells were 
transfected with 0.8 μg of DNA of pEGFP-actin14 (Clontech, Mountain View, 
CA) and GFP-Zyxin using Lipofectamine-Plus reagent according to the manu-
facturer’s procedures (Invitrogen). Stable transfectants were selected using 
800 μg/mL G418. Individual clones were picked and maintained in complete 
medium containing 100 μg/mL G418. Clones were analysed for expression of 
GFP-actin and GFP-zyxin using immunofluorescence.
Flow cell preparation and cell loading
After the microfluidic flow cell was perfused first with a collagen solution 
(30μg/mL) for an hour at room temperature and secondly with the medium 
for 10 minutes, after a cell suspension of 3 million cells per mL was introduced 
into the channels. When the channel was fully loaded with cells the cell sus-
pension vial was replaced by a vial of fresh medium such that inlet and outlet 
of the microfluidic channel have a medium reservoir. The microfluidic flow 
cell was then placed in the incubator at 37°C for 1 hour to allow the cells to 
adhere. Three to five days elapsed until the cells had grown at about 80% con-
fluence. During incubation of the cells in the incubator the vials with medium 
are placed higher than the flow cell such that the channels experience a slight 
hydrostatic pressure of medium. As PDMS is permeable to air, the medium in 
the channel slowly evaporated but was refilled with medium from the flasks.
Live cell imaging
Bright field, fase contrast imaging
During cell culture incubation, cell confluence was monitored daily using a 
standard fase contrast transmission Nikon TMS microscope using a 20X plan 
apo NA 0.75 lens objective. 
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specimen8-11. Here, we quantify the changes in phenotype of renal proximal 
tubule cells using live confocal microscopy. The FSS within the renal tubular 
system is estimated in the range of 0.2-20 dyn/cm2 which is about 10% of that 
of the endothelial cells15. In our study, we chose to apply a FSS of 6 dyn/cm2 
which may be relevant for understanding FSS induced renal disease progres-
sion. Subconfluent LLC-PK1 cells were cultured for 3 days and then exposed 
to either ~0 or ~6 dyn/cm2 for 12 hours (Fig. 2.4(a) and Sup. Mov. 2.2). 
aged using various microscope techniques. The advantages of each technique 
for studying the actin cytoskeleton in LLC-PK1 cells expressing ectopically 
GFP-actin are visible in Fig. 2.3(b). Differential Interference Contrast (DIC) 
microscopy image allows for detailed studies of membrane structures, such 
as the outer cell-membrane and nucleus. Using Total Internal Reflection Fluo-
rescence (TIRF) microscopy, the actin cytoskeleton can be imaged up to the 
first 100 nm above the bottom of the microfluidic channel. It shows the focal 
adhesions as separate bright spots. Confocal microscopy allows studying fluo-
rescently labeled actin, close to the surface, but including structures such as 
fibres which are invisible to TIRF microscopy. One single plane of a 3-D stack 
of confocal images is visible in Fig. 2.3(CONFOCAL).
Shear-stress results in enhanced motility in 
renal epithelial cells
Having established a platform which can be used for stable cell culture in mi-
crofluidic channels, and allows for high resolution dynamic live cell imaging, 
we were interested in analysing differences between fluid shear-stimulated 
and non-stimulated cells. Previous studies have shown that fluid shear stress 
induces changes in phenotype in renal cell, based on imaging results of fixed 
Figure 2.3 Cell culture in a microfluidic channel of the flow cell. In (a), phase contrast microscope im-
ages of cells growing in a flow cell during three weeks, scale bar is 100 μm. In (b), the same group of cells 
is imaged using different microscope live cell imaging techniques, scale bar is 20 μm.
Figure 2.4 Cell tracking analysis of confocal time lapse series of LLC-PK1 cells expressing ec-
topically GFP-actin. Cell nuclei were manually tracked in sheared and control cells, scale bar is 20 
μm (a). Quantification shows a significant increase in cell motility of sheared cells (b).Tracked tra-
jectories show that cells subjected to a flow are more motile, but not in a preferred direction (c). 
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Mov. 2.3). Cells not exposed to the laminar flow showed little rearrangement 
in their actin meshwork, or only random formation of small ruffles at the cell 
border. In contrast, the creation of a laminar flow resulted in a strong reor-
ganization of the actin cytoskeletal network with the formation of large lamel-
lipodia in most of the cells located on the edge of an island and active mem-
brane ruffling at cell-cell contacts. The change in membrane dynamics could 
be quantified by making a kymograph of the lamellar region of the control and 
sheared cells (Fig. 2.5(c)).
FSS induces actin stress fibres and cortical ring formation
Next to the active membrane ruffling, we observed a change in F-actin distribu-
tion over the time of the experiment. In the no-flow treated cells, GFP-actin local-
ized preferentially at cell-cell contacts in a relatively thin disorganized actin network. 
Exposure of the cells to FSS caused formation of arranged thin bundles of actin 
throughout the cells. In addition, cells became more motile and strengthened their 
junction by forming a continuous and organized cortical actin network. Imaging of 
cells expressing the mechanosensitive protein zyxin16 shows that upon FSS zyxin 
disappeared from the focal adhesions bound to actin filaments to localize to the 
junction between cells. Thus, LLC-PK1 cells exposed to FSS induced a significant re-
inforcement of intercellular junctions. Unlike previously described for epithelial cells, 
the actin cytoskeleton of unsheared PK1 cells demonstrated few and weak cytosolic 
actin stress fibres (Figure 2.6(a)). Laminar flow (1 mL/min, 6 dyn/cm2) for 12 h 
induced a formation of cytosolic actin stress fibres and a reinforcement of the lateral 
actin network (Figure 2.6(b)). This was also confirmed with the live cell imaging of 
LLC-PK1 cells expressing GFP-zyxin: upon shear stress, zyxin containing matrix ad-
hesions redistribute from the ventral side to the periphery of the cells (Sup. Fig. 2.1 
and Sup. Mov. 2.4), which correlates with the formation of strong tight junctions. 
 In conclusion, we demonstrated that our microfluidic device is adapted for 
studying in details the dynamics of the cytoskeleton in cells upon shear stress.
Discussion
Using our novel device to apply shear stress to LLC-PK1 cells confirmed pre-
viously published results and also provided more detailed information on the 
cytoskeletal reorganization upon FSS in time and space. FSS induced higher 
During exposure, the cells were imaged by confocal microscopy to monitor 
the change in phenotype upon FSS. Manual cell tracking of cells grown to sub-
confluence upon mild shear stress of 6 dyn/cm2 shows significant increased 
movement (Fig. 2.4(b)), but not in a preferred direction (Fig. 2.4(c)) with 
respect to the fluid flow as it is the case for endothelial cells. These results 
indicate that renal epithelial cells are FSS sensitive and show increased motility 
upon fluid shear stress.
FSS induces rapid lamellipodia formation
Since confocal time lapse image sequences of the actin cytoskeleton were 
acquired at 10 min intervals for 12 hours we could quantify the change in 
phenotype of the renal cells. Within the first hour of shear stress application, 
lamellipodial protrusion was induced at cell periphery (Fig. 2.5(a,b) and Sup. 
Figure 2.5 Lamellipodia formation in LLC-PK1 cells subjected to FSS. Shear stress induces 
lamellipodia formation (see arrows indicating newly formed lamellipodia (a). Quantification 
of cells showing high membrane ruffling activity, scale bar is 20 μm (b). A kymograph of a cell 
boundary shows the lamellipodia formation in more detail (c) 
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motility of the LLC-PK1 cells which was associated with increased activity 
of the membranes ruffles. During the course of the experiments with a FSS 
of 6 dyn/cm2, the actin cytoskeleton reorganizes in a cortical ring together 
with stress fibres. Cell-cell junctions become stronger and zyxin, a mecha-
nosensitive protein disappear from the focal adhesions to localize at the cell-
cell contacts. Those observations are opposite to those made for endothelial 
cells but fit partially with observations made on proximal tubular cells8-11. The 
reorganization of cytoskeleton observed in epithelial cells is not identical to 
that observed in endothelial cells where the actin stress fibres strengthen and 
align along the flow direction14. In contrast, tubular epithelial cells do not align 
to the direction of the flow, show high motility and reinforce the apical and 
lateral domains of actin filaments. The polymerisation of new actin filaments 
is necessary for the cell motility and is probably weak in the no-flow cham-
ber since the cells are cultured for a long period of time. High cell motility 
was quantified using time-lapse microscopy where LLC-PK1 cells appeared to 
switch to a motile phenotype within minutes after the onset of the laminar 
flow. At the same time, within an hour after the start of the experiments, 
massive membrane ruffling occurred as it was previously observed in podo-
cytes17. Renal cells loss in the flow chamber occurred rarely. In response to 
shear stress, the renal cells may adopt an intermediate adhesiveness (zyxin 
re-localization), which enables the cells to be more motile but also contrib-
utes to increased detachment upon force application. Renal cells seem to weaken 
their adhesions, rearrange their actin cytoskeleton to be able to migrate. Indeed, 
cell migration requires persistent lamellipodial protrusion and actin filament poly-
merisation which was indeed observed in our study. The induction of a migratory, 
intermediate adhesive phenotype and the reorganization of the actin cytoskeleton 
in a nonpolarized fashion would fit with the in-vivo situation e.g. remodelling after 
substantial renal mass reduction. This specificity of cytoskeleton reorganization 
induced by flow depends on the function of the cell. 
 The microfluidic flow cell is very user friendly. It fits together with the me-
dium reservoirs in a standard incubator, is quite robust in use, can be steam 
autoclaved, and fits in a standard microscope-glass holder. The passive con-
figuration allows to culture cells in many chips in parallel. During transport 
the chip is closed, thus sterile, and including the small vials it’s a small package 
which fits in one hand. It is compatible with inverted/upright and transmission 
microscopes, bright-field, DIC fluorescence, confocal and TIRF microscopy. We 
used small angular gear pumps for the flow experiments, which also fit inside 
Figure 2.6 Stress fibres formation and actin network reinforcement. Shear stress induces 
actin fibres formation (see arrows indicating newly formed stress fibres), scale bar is 20 μm (a). 
In addition, FSS results in the reinforcement of the actin network at the cell-cell contact, scale 
bar is 20 μm (b). In conclusion, we demonstrated that our microfluidic device is adapted for 
studying in details the dynamics of the cytoskeleton in cells upon shear stress.
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Conclusions
We have developed a versatile easy to handle microfluidic flow cell adapted for 
live cell high resolution imaging, by using a newly designed side-connection for 
tubing. Biological testing revealed that different cell types grow normally in this 
new type of microfluidic circuit. Furthermore, using live cell imaging together 
with confocal microscopy, we were able to show the dynamics change of re-
nal cells under FSS conditions. When shear stress was applied, we observed 
enhanced cell migration coupled to ruffle formation and actin rearrangements 
(e.g. shortening and thickening). 
 Our described methodology can be systematically applied on different cell-
types and imaging technologies. In future applications the system could be used 
for high content imaging of various biological assays including FSS, chemotaxis 
or on-chip flow cell differentiation19.
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nm, while MPs may have sizes far below this wavelength9. Yuana et al.10 reported 
the presence of MPs bearing CD41 antigen in plasma with sizes ranging between 
10-475 nm using atomic force microscopy (AFM). They also found that the MP 
numbers detected by AFM are 1,000-fold higher than those detected by FCM. 
Although capture-based assays using annexin V or MP-specific antibodies allow 
high throughput assessment of procoagulant features of MPs11,12,13, these assays 
give no information on the size and total number of MPs in plasma. 
 Electron microscopy (EM) has been used for detection of MPs14,15,16, but this 
method only provides semi-quantitative information on MPs. Furthermore, sam-
ple dehydration and vacuum procedures required in EM might affect the char-
acteristics of MPs. Recently, a promising method, nanoparticle tracking analysis 
(NTA), has been applied to count MPs in plasma17. This method uses a CCD 
camera system that allows simultaneous tracking of multiple particles. In the fu-
ture NTA may be able to detect, count, and size antibody-labeled MPs efficiently, 
thus allowing the detection of subsets of MPs.
 Not only is the analytical measurement of MPs a challenge, but also there is 
no golden standard yet to prepare MPs18. Many studies have isolated MPs from 
platelet free or platelet poor plasma by applying high speed centrifugation or 
even ultracentrifugation19,20. To prevent loss and phenotypic changes of MPs 
during the isolation procedure, using blood plasma directly for MP measurement 
would be preferable21. Furthermore, the time between blood withdrawal and 
the actual MP test should be as short as possible to avoid activation of cells and 
coagulation processes which may affect MP numbers and characteristics. 
 We propose a method to detect MPs directly in blood plasma by using a mi-
crofluidic flow cell and performing subsequent analysis using AFM in liquid-tapping 
mode. Laminar flow patterns within the flow cell ensure complete fluid turnover 
in a controlled manner. The flow cell allows experimentation with very small sam-
ple volumes. In this study, a detachable flow cell was developed to enable direct 
contact between the fluid in the microfluidic channel and the surface. Diluted plas-
ma was flown through the microfluidic channel with a controlled pressure driven 
laminar flow and made to be directly in contact with anti-CD41 antibody-coated 
mica. MPs exposing CD41 antigen were captured on this surface and subsequently 
imaged by AFM. We employed the AFM method for MP detection previously used 
in the study of Yuana et al.10. 
 Clotting of the plasma and clogging of the microfluidic channel pose a po-
tential problem within such small volumes and with such a sensitive detection 
method as AFM. These problems have been solved by diluting plasma with either 
Abstract
Microparticles, also known as microvesicles, found in blood plasma, urine, and 
most other body fluids, may serve as valuable biomarkers of diseases such as 
cardiovascular diseases, systemic inflammatory disease, thrombosis, and cancer. 
Unfortunately, the detection and quantification of microparticles are hampered 
by the microscopic size of these particles and their relatively low abundance 
in blood plasma. 
 The use of a combination of microfluidics and atomic force microscopy 
to detect microparticles in blood plasma circumvents both problems. In this 
study, capture of a specific subset of microparticles directly from blood plasma 
on antibody-coated mica surface is demonstrated. The described method ex-
cludes isolation and washing steps to prepare microparticles, improves the 
detection sensitivity, and yields the size distribution of the captured particles. 
The majority of the captured particles have a size ranging from 30 to 90 nm, 
which is in good agreement with prior results obtained with microparticles im-
mediately isolated from fresh plasma. Furthermore, the qualitative shape of the 
size distribution of microparticles is shown not to be affected by high-speed 
centrifugation or the use of the microfluidic circuit, demonstrating the relative 
stable nature of microparticles ex vivo.
Introduction
Blood microparticles (MPs), also known as microvesicles, are small particles shed 
from the surface of many cells upon stimulation or apoptosis1. For a long time 
they were considered as platelet dust2, but now they have been recognized to 
participate in important biological processes3. Examples of such processes are 
surface-membrane traffic and the horizontal transfer of protein and RNAs among 
neighboring cells, which are necessary for rapid phenotype adjustments in a variety 
of conditions3. In addition, blood MPs have important physiological and pathologi-
cal roles in blood coagulation, inflammation and tumor progression4. 
 Flow cytometry (FCM) and capture-based assays are commonly used meth-
ods to measure the number of MPs, define their origin based on membrane 
antigen expression, and asses their procoagulant features6,7,8. However, these 
methods have their drawbacks. FCM employs laser light which excites at 488 
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during polymerization. The top surface of the ridges is polished to allow viewing 
through the channel from bottom to top after molding. At the end of the ridges, 
small holes are drilled and small pins are inserted with a diameter of 1 mm and a 
height of about 1 mm.
Flow cell: fabrication
Polydimethylsiloxane (PDMS) flow cells are fabricated using a Sylgard 184 kit (Dow 
Corning, UK). Silicone primer and catalyst are mixed in a 10:1 ratio by weight and 
this mixture is placed in a vacuum chamber for 1 h to remove air bubbles trapped 
during mixing. Next, the mixture is slowly poured into the mold and then the mold 
is carefully closed with a glass plate. The mold containing the polymer solution is 
placed in an oven at 70°C for 1 h. Afterwards, the glass slide with the PDMS flow 
cell is released from the mold and covered with a clean glass slide to keep the chip 
channel area dust-free. The polymerized flow cell is shown in Figure 3.1a.
Flow cell: setup
The complete microfluidic setup is shown in Figure 3.1b. To prepare the flow 
cell setup, a mica surface (1) is placed on a metal support disc (2). The metal sup-
port disc is placed onto the bottom plate of the holder device (4), in a small cav-
ity that closely fits the metal disc. The PDMS flow cell (3) is placed onto the top 
plate with the open microfluidic channels facing down. Two pins, situated in the 
holder top plate (5) align the flow cell (see the two holes next to the channels in 
Figure 3.1a) with respect to the mica surface and the holes for the glass capil-
laries (7) (TSP Fused Silica Tubing, ID/OD 150/375 micrometer, deactivated with 
DPTMDS, from BGB Analytik Vertrieb, Germany). Then the top and bottom plate 
are pressed onto each other with four screws (6). Using microscopic inspection 
the screw pressure is carefully adjusted. The glass capillary tubes are beveled to 
45 degrees before use, using a mechanical grinder (Michael Deckel S0) with a disc 
containing diamond dust. After careful rinsing with water, to remove remaining 
grinding dust, the glass capillary tubes are gently forced into the PDMS flow cell, 
and guided through alignment holes situated in the holder top plate.
Mica Surface preparation for attachment of anti-human 
CD41 monoclonal antibody
The surface of mica (Electron Microscopy Sciences, Washington) for MP at-
citrate or EDTA-enriched Hepes buffer and coating the microfluidics channels 
and the tubing of the microfluidics system. We demonstrated that this method 
increases the sensitivity of detecting specific MPs in a sample 100 to 1,000-fold. 
In conclusion, the application of a flow cell allows the AFM measurement of a 
specific subset of MPs directly in blood plasma.
Materials and Methods 
Blood collection and plasma preparation
After giving their informed consent, venous blood of three healthy volunteers is 
collected by using a 21-gauge needle (BD Vacutainer, San Jose, CA) with minimal 
stasis. Except for the first four mL, the blood is collected either in 1/10 volume 
of sodium citrate (3.2%, 0.105 M) or in K2 EDTA (3.6 mg) using 4.5 mL BD Va-
cutainer tubes (Becton Dickinson, San Jose, CA). Within 10-15 min after with-
drawal, the collected blood is centrifuged at 2,000g for 10 min at 20°C, without 
brake. The supernatant plasma is carefully collected and centrifuged again at 
2,000g for 10 min, 20°C, without brake, to obtain platelet poor plasma (PPP). 
PPP was aliquotted in 250 μL portions, snap frozen in liquid N2, and stored 
at -80°C until used. Before use, PPP is quickly frozen-thawed at 37°C. Unless 
stated otherwise PPP is used in the experiments.
Microparticles isolation
For MP isolation, 750 μL of frozen-thawed citrate PPP is centrifuged at 18,890g 
and 20°C for 30 min, with minimum brake. The supernatant is removed care-
fully, except for 25 μL containing the MP pellet. This pellet is resuspended in 1 
mL of Hepes buffer [10 mM Hepes (Merck, Darmstad, Germany), 137 mM NaCl 
(Merck), 4 mM KCl (Merck), 0.1 mM Pefabloc SC (Fluka, Munich, Germany), pH 
7.4], vortexed, and centrifuged as before. The supernatant is removed, leaving 
a volume of 25 μL containing the MP pellet. Subsequently, this 25 μL is carefully 
diluted in 725 μL of Hepes buffer to reconstitute to the original plasma volume 
(750 μL) before use in the experiment. 
Flow cell: mold fabrication
A flow cell mold is fabricated from brass. This brass is milled so that ridges with di-
mensions of 10 mm x 300 μm x 100 μm are created that shape the liquid channels 
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tachment is prepared as described before10 with a slight modification. Freshly 
cleaved mica disks (diameter 12 mm) are overnight immersed in DMSO contain-
ing 55% (w/v) ethanolamine at 70° C. Subsequently, the mica surfaces are rinsed 
twice with dry DMSO at 70°C and then with HPLC grade ethanol to remove the 
DMSO. Next, the mica surfaces are put for 10 min into 30 mL phosphate buff-
ered potassium (PBK) (10.2 g KCl, 0.97 g K2H2PO4 and 5.71 g K2HPO4 per L) 
(pH 7.4) previously saturated with EGTA by adding 100 mg EGTA. The surfaces 
are then rinsed with Hepes buffer, before 20 μL of 0.05 mg/mL (in Hepes buffer) 
mouse anti-human CD41 antibody clone P2 (Beckman Coulter, Fullerton, CA) 
is applied to the surface and incubated for 3 h. Excess anti-CD41 is removed 
by washing with Hepes buffer. Anti-CD41 antibody coated-mica surfaces are 
stored in Hepes buffer until used. As a negative control, mouse IgG1 pure clone 
X40 (Becton Dickinson, San Jose, CA) is used (0.05 mg/mL in Hepes buffer). The 
IgG1 isotype control antibody is allowed to incubate for 3 h on the functional-
ized mica surfaces. All chemicals are purchased from Sigma Aldrich (Munich, 
Germany) unless otherwise indicated. 
 Prior to the attachment of MPs antibody-coated mica surfaces were inspected 
by using AFM to ensure that the number of false spots and holes in the antibody 
coating was minimized.
Attachment of microparticles without using microfluidics
PPP (100 μL EDTA plasma) is dropped onto the mica surface coated with IgG1 
isotype control and anti-CD41 antibody (“drop method”). To check the satura-
tion of MPs on the anti-CD41-coated surface, PPP is incubated on the surfaces 
for 2, 30, and 60 min. Similar to what was found by Yuana et al10, 30 min incuba-
tion seemed to be sufficient. On anti-IgG1-coated surface PPP was incubated for 
60 min to match the long exposure time on the anti-CD41 surface. The surfaces 
are carefully rinsed with Hepes buffer and then scanned by AFM to determine 
the number of MPs captured on CD41- and IgG1 isotype control- coated mica 
surfaces.
Attachment of microparticles using microfluidic flow cell
The open microfluidic flow cell (PDMS) is attached to a mica surface as described 
above. A 1 mL-syringe (Becton Dickinson, San Jose, CA, USA) is connected to 
a Harvard Apparatus PicoPlus (Harvard apparatus, Holliston, MA, USA) syringe 
pump and set at a constant flow speed of 0.01 mL/min. The syringe is connected 
to the glass capillary tubes using Luer-Lock Adapters and One-Piece Fittings 
Figure 3.1 Flow cell setup (a) Open PDMS flow cell. (b) Microfluidic flow cell setup with 
schematic side view. The holder system (4,5,6) is used to press the PDMS chip (3) onto the 
mica surface (1). The glass capillary tubes (7) are guided through holes in the holder top plate 
(5) to reach the connection chambers in the chip (3). The metal disc (2) is used as a support 
for the mica surface. In the photo (c), the middle channel is connected and filled with a dark 
blue solution; the glass capillary tubes are bent towards the side using scotch tape. The dark 
solution and scotch tape are for illustration purposes and are not used in experiments.
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flow cell. Anti human-CD41 antibody was used to coat the functionalized mica 
to capture platelet MPs (PMPs) bearing CD41 surface antigen. PMPs constitute 
80-95% of blood MPs detected by FCM22,23. The IgG1 isotype control is used 
as a control for nonspecific binding of MPs on anti-CD41-coated surface. A 
schematic overview of the experiment is given in Figure 3.2. The microfluidic 
setup used in Figure 3.2b is constructed from a PDMS flowcell (Figure 3.1b), 
attached to the mica surface by a removable holder system (Figure 3.1b,c) so 
that the flow cell can be removed from the surface of the sample without damag-
ing either the attached MPs or the mica. 
Application of microfluidic system to count MPs in plasma
With microfluidics many more MPs in the plasma sample will have a chance 
to interact with the antibody-coated mica surface by flowing an equal volume 
of plasma over a very small active surface area in the confined volume of the 
microfluidic channel. To examine this we applied the microfluidic system and 
compared it with the drop method to count MPs in plasma obtained from two 
healthy donors. For the microfluidic system two samples were prepared: the 
first sample consists of MPs isolated from citrate PPP, reconstituted to the origi-
nal plasma volume, and subsequently diluted 5 times with Hepes buffer; the 
second sample is EDTA PPP diluted 5 times with EDTA-enriched Hepes buffer. 
For the drop method undiluted EDTA plasma is used. 
from LabSmith (Livermore, CA, USA). The glass capillary tubes are gently forced 
into the microfluidic chip using the beveled end.
 The channels of the cell are rinsed with 50 μL EGTA-enriched Hepes buffer 
(5 mM EGTA, 10 mM Hepes, 137 mM NaCl, 4 mM KCl, 0.1 mM Pefabloc® SC, 
pH 7.4) buffer for about 5 min. Hundred fifty μL of either EDTA plasma diluted 
with EDTA-enriched Hepes buffer (20 mM EDTA (Sigma Aldrich), 10mM Hepes, 
137 mM NaCl, 4 mM KCl, 0.1 mM Pefabloc® SC, pH 7.4) or isolated MPs diluted 
with Hepes buffer is allowed to flow through the channel in the flow cell for 
about 15 min total flow time. The channel is then rinsed with 50 μL Hepes buf-
fer (~5 min flow time). Before removal from the flow cell, the back of the mica 
is carefully marked to indicate the location of the channel in the AFM. Subse-
quently, the flow cell is removed and the coated surface with the attached MPs 
is rinsed with Hepes buffer and stored in Hepes buffer until imaged by AFM. All 
steps are performed at room temperature (RT).
AFM imaging
AFM imaging is performed with a Digital Instruments Multi-mode AFM (Veeco, 
New York, NY, USA) using the E scanner. Olympus cantilevers (Olympus, To-
kyo, Japan) with force constant of 2 N/m and a resonant frequency of 70 kHz are 
used. The liquid cell tip holder (Veeco) is rinsed with ethanol and milli-Q water 
between each sample to prevent contamination. Each image was scanned at 10 x 
10 μm and 10 images are taken at a variety of locations on the surface. For each 
particle, the sum of pixel heights multiplied by the pixel area is used to estimate 
a volume and subsequently to calculate its (spherical) diameter. 
Results
Generally, glass, polymer or similar materials are used with microfluidics. How-
ever, the AFM cantilever must have physical access to the top of the sample 
and AFM requires an atomically flat background to give the best image of the 
sample. Mica is preferred surface material because it has distinct atomically flat 
layers that can be easily separated for cleaning and functionalization. As PDMS 
binds strongly to mica, the mica surface can be pealed away when the PDMS is 
removed, ruining the sample. In our study, the mica surface is functionalized with 
antibodies to produce a hydrophilic mica surface that cannot bind to the PDMS 
Figure 3.2 Schematic overview of experiments Collected blood plasma is centrifuged 
twice to acquire PPP. In some experiments blood plasma proteins are removed by use of 
high-speed centrifugation (a). Using an antibody coated mica surface, a fresh PDMS chip and a 
holder system a microfluidic setup is build, and the PPP is run over a small surface area (b). Fi-
nally, mica surface is removed and imaged using AFM, followed by automated image analysis (c).
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EDTA plasma are not significantly different (see Figure 3.S1 in the supplemen-
tary information).
 Despite the fact that macroscopic clotting could be prevented by diluting 
EDTA PPP with EDTA-enriched Hepes buffer, we noticed in preliminary experi-
ments that there still was some clotting in the small confinements of the micro-
fluidic channel. In some studies it has been shown that unmodified PDMS is not 
compatible with some of the blood/plasma components and may initiate activa-
tion of the clotting system26,27. Platelets adhere more strongly to the surface of 
unmodified PDMS than to the modified PDMS28. Moreover, unmodified PDMS 
is hydrophobic and this might induce clotting when plasma is introduced in the 
microfluidic channel29,30. To prevent this clotting in the microfluidic channels, a 
solution of EGTA-enriched Hepes buffer was flowed through the channel before 
application of the plasma. EGTA is also known as a strong chelator of calcium 
ions, but it is not known to the authors whether the EGTA also can physically be 
adsorbed on the PDMS, acting to prevent clotting on the surface of the channel, 
or if EGTA performs its anti-clotting action in some other way.
Analysis of AFM images
The AFM images provide a unique challenge for image processing. As images are 
generated by scanning line after line, each neighboring line scan can have a dif-
ferent offset, slope or parabolic background (Figure 3.3a,e). This background 
must be dealt with for the accurate determination of neighboring scan lines to 
calculate the heights and volumes of the MPs correctly. The most commonly 
used techniques involve performing linear regression on the fast scan line and 
then subtracting the background estimate from each line. This technique is fre-
quently foiled by small, high features on the surface, such as MPs. To overcome 
this difficulty, a special technique is developed in our lab. First, a standard linear 
regression subtraction is performed (Figure 3.3b,f). Second, Labview IMAQ is 
used to find all the particles (Figure 3.3c,g). Third, the regions containing the 
particles are then removed from the background subtraction input and the lin-
ear regression subtraction is performed again to provide a much flatter surface 
(Figure 3.3d,h). While this is a computationally expensive task, it provides the 
high precision background subtraction for the needed accurate determination of 
the particle volumes.
Particle counting is performed by using the Labview IMAQ library to determine 
the location of the particles. The Count Objects 2 VI is first used to filter and 
obtain a list of possible particles. This software uses a threshold to make a binary 
 In all samples processed by the microfluidic system, the AFM detected MPs at-
tached on anti-CD41-coated mica surface (Table 3.1). The attachment of these 
MPs was specific because there were at least two times less particles found at-
tached on the IgG1-coated surface compared to those on the anti-CD41-coated 
surface (Table 3.1). This also confirms that these MPs bear CD41 surface anti-
gen (CD41-positive MPs). Using image quantification software we found in the 
samples processed by microfluidic system that there is no significant difference 
in the number of MPs attached on anti-CD41-coated surface (218, 276, 203, 
and 240 MPs/100 μm2). Strikingly, there were hardly any MPs captured on anti-
CD41 coated-surface by using the drop method, even after one hour incuba-
tion of plasma on the surface (3 MPs/100 μm2 anti-CD41-coated surface and 3 
MPs/100 μm2 IgG1-coated surface, Table 3.1).
 It has been reported in the literature24,25 that when EDTA is used as anti-
coagulant for blood collection, the CD41/CD61 complex on the plasma mem-
brane of platelets may loose their affinity for anti-CD41 and CD61 antibodies. 
To check this we have used FCM to measure the binding of anti-CD61 and 
anti-CD41 antibodies to platelet MPs in citrate- and EDTA-anticoagulated blood 
plasma. We found that the numbers of CD41/CD61-positive MPs in citrate and 
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Table 3.1 Comparison of microfluidic method and drop method to count CD41-
positive MPs For the microfluidic method MPs isolated from citrate PPP and diluted EDTA 
PPP of two healthy donors, D1 and D2, were used. Isolated MPs were reconstituted to the 
original plasma volume and subsequently five-fold diluted in Hepes buffer (Reconstituted isolat-
ed-MPs D1/D2). EDTA PPP was diluted five-fold with EDTA-enriched Hepes buffer (EDTA 
plasma D1/D2). For the drop method undiluted EDTA PPP from the same healthy donors was 
used (EDTA plasma drop D1/D2).
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be applied throughout a large dataset of AFM images.
 As can be deduced from Figure 3.3 the height is smaller than the width in 
detected MP profiles, the MPs appear disc shaped after binding to the surface. 
Using the disc radius and height, the particle volume is estimated and converted 
into an effective diameter assuming that MP have a spherical shape in solution10. 
This procedure ignores the effects of tip flattening. It seems that this does not 
have a major effect on the final calculated volume of the particles (results not 
shown), and only a small systematic error exists in the volume calculations from 
the tip broadening effect. The size distribution of the example image is shown in 
Figure 3.3i.
 Size distribution graphs are made to further analyze possible differences be-
tween MPs captured from diluted isolated MPs and from diluted EDTA plasma, 
to see if high-speed centrifugation has an effect on the particle size. No significant 
differences in the number and size distribution of CD41-positive MPs was ob-
served before and after high-speed centrifugation (supplementary Table 3.S1, 
supplementary Figure 3.S2). As mentioned before, we do not need to concen-
trate particles using high-speed centrifugation, however the clotting probability is 
strongly reduced by removal of blood plasma proteins. Therefore we use purified 
MPs, reconstituted to the original volume for all further experiments.
Relationship between MP concentration and number of 
MPs captured on anti-CD41-coated surface
Prior to measuring the concentration of MPs in a sample, the dynamic range 
should first be established. Therefore we used MPs isolated from frozen-thawed 
citrate PPP of a healthy volunteer. Isolated MPs are first reconstituted with 
Hepes buffer to reach the original plasma volume before isolation (100%) and 
subsequently diluted 2 to 40-fold. These diluted MP fractions are run through 
the microfluidics system to measure the number of captured CD41-positive 
MPs. Figure 3.4a shows that only at sufficiently low concentrations (<10%) 
there is a linear relationship between the MP concentration and the number of 
particles attached on the anti-CD41-coated surface. Probably because of un-
specified binding in the microfluidics circuit the line does not cross the ori-
gin (0,0). At higher concentrations (>10%) the number of MPs captured to the 
anti-CD41-coated surface reaches a maximum of ~250 particles/100 μm2. This 
number of captured MPs is very similar to those reported in Table 3.1 for the 
reconstituted isolated MP fraction and EDTA plasma which are diluted 5 times 
before processing with the microfluidic system. 
image, and then uses the watershed method to count the particles. Particles that 
touch the boundaries will not be counted. Additionally, all holes within the par-
ticles are automatically filled. The lower limit of height, width, and breadth of the 
particles is set to separate them from the background. For counting, the particle 
must at least 3 nm high and occupies at least 3 pixels. The particle must be larger 
than 1 pixel in width or breadth. By setting this limit constant selection rules can 
Figure 3.3 AFM image quantification Original AFM image, intensity represent height, see scale 
bar on the right side (a). This image is flattened using the standard linear regression background 
subtraction (b). White squares show all the particles that are found on the image from image A 
(c). The background is subtracted, corrected for the shadowed regions, and the particles are cor-
rectly sized (d). The bottom row (e,f,g,h) shows an enlarged region of (a,b,c,d) respectively, scale is 
500 nm. The measured particles are indicated with red ellipses (d,h). The size distribution graph of 
particles detected from this image (100 µm2) is depicted (i).
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 The AFM images show that, typically, the particles are not uniformly distrib-
uted on the surface (Figure 3.3a). As a result, the standard error of the mean 
is quite large (Figure 3.4a). The linear range is rather small, and it may be dif-
ficult to find a suitable working range when samples differ as strongly in particle 
counts as mentioned before10. Interestingly, it is found that the size distribution 
does not differ significantly between different images (Figure 3.4b), and differ-
ent dilutions (Figure 3.4c, Supplementary Table 3.2) of the same sample, 
with the exception of the highest dilution. This sets microfluidic capture com-
bined with AFM imaging as the first method able to measure the size distribution 
of a specific subset of MPs directly in PPP.
Figure 3.4 Relationship between the MP concentration in the sample and the num-
ber of CD41-positive MPs detected by AFM MPs isolated from frozen-thawed citrate PPP 
are diluted from 50% to 2.5% (100% is undiluted reconstituted-isolated MPs) in Hepes buffer 
and run through the microfluidics device (a). These experiments were done on two different 
days using the same plasma pool of one healthy volunteer. The size distribution from a single 
dilution (3.8%) is based on three images (b). A normalized size distribution of all dilutions aver-
ages is weighted equally (c). Scale bars represent the standard error of the mean.



















































































*Values based on calculated particle diameter in nanometer
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Therefore, when this present method will be used as a diagnostic tool, the 
throughput needs to be increased by developing high speed AFM and automated 
sample handling. Additionally, if fluorescent labeling can be implemented effi-
ciently, the number of particles captured should allow optical detection of these 
particles by means of fluorescence imaging. With the AFM technique being used 
for calibration, it should be possible to fluorescently tag the MPs to provide opti-
cal quantification of the number of MPs on the mica surface.
Conclusion
In this study, it is demonstrated that by using a removable microfluidic circuit, CD41-
positive MPs can be captured directly from diluted blood plasma, and detected by 
AFM. Quantification of MPs is automated, to allow consistent and fast quantification. 
Use of the microfluidic system increases the sensitivity of MP detection consider-
ably, leading to a higher surface concentration of attached MPs, reducing the AFM 
scanning time. Direct use of plasma as opposed to isolated MPs shortens the pre-
processing time and enables the detection of MPs in a more natural state. Ten μL 
EDTA plasma is sufficient to quantify the number and determine the size distribution 
and shape of CD41-positive MPs using microfluidics and AFM.
 In future experiments the characterization of MPs from other origins (endo-
thelial cells, monocytes, tumor cells, etc) by using antigen-specific monoclonal 
antibodies will be addressed. This will help in monitoring subsets of MPs that 
may play a specific role in the development of certain diseases.
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Discussion 
We report on a novel method to identify and characterize a specific subset of 
MPs directly in plasma. To enable the measurement of MPs directly in plasma, 
we have developed a method that combines a microfluidic system and AFM 
detection. Microfluidic channels allow blood plasma to flow over a small surface 
of antibody coated mica, resulting in a high enough surface concentration of 
specifically bound MPs to detect and quantify using AFM. A much higher number 
of MPs is captured from (diluted) plasma on antibody-coated mica than without, 
using this microfluidic method (plasma drop system). Further optimization of the 
method is required for high-throughput measurements. 
 For the first time it is demonstrated that the size distribution of CD41-pos-
itive MPs is robust against high-speed centrifugation and dilution. However, to 
prevent clotting to occur, the use of MPs isolated by means of high-speed cen-
trifugation is advised.
 Yuana et al10 have shown that MPs isolated from fresh citrate PPP have cal-
culated, spherical like diameters (dsph) of ~50 nm (range 10-475 nm). Using 
microfluidics we found that MPs isolated from frozen-thawed citrate PPP and 
frozen-thawed EDTA PPP have a similar calculated diameter (dsph) of ~45 nm. 
Software has been developed to automate the measurement and counting of 
MPs. This results in much more consistent results and provides faster data analy-
sis. By comparing the results from previous experiments by Yuana et al10 to the 
new automated quantification of the same dataset we observed that the size 
distribution was similar to those reported earlier (data not shown).
 There are advantages and disadvantages in using the microfluidic system and 
AFM to measure MPs. In this study we found that about 10 μL of plasma is enough 
to count significant number of MPs and determine their size distribution. Fur-
thermore, the microfluidic system allows the measurement of MPs directly in 
plasma thus reducing time between venepuncture and MP measurement and also 
preventing MP loss because of washing steps in the isolation procedure. However, 
the preparation of mica (modification and coating) typically takes two days. In 20% 
of all cases we also dealt with leakage from microfluidic channels during plasma 
injection. AFM scanning of the surface is also time-consuming. It takes at least an 
hour finding a right surface to position the AFM tip and scanning 10 images of 100 
μm2 at different locations on the surface. 
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tion, pro-inflammatory cytokine secretion and phagosome maturation9.
 The alarming rate of emergence of new drug resistant (MDR/XDR) M. tu-
berculosis strains isolated from patients, in particular HIV-infected individuals, 
is cause for global concern, and the race for more efficient vaccines, as well 
as novel antibiotics targeting either the pathogen or the host, has begun3,10,11. 
While in-vitro models have shed light on processes that are central to the uptake 
and survival of the bacterium, they cannot recapitulate the full phenotype of la-
tent M. tuberculosis infection. This has been partly circumvented through the use 
of non-human primate models, which develop a form of TB that exhibits many of 
the hallmarks of the human infection12. However, although the guinea pig model 
has been used to validate anti-TB vaccines and drugs13 and mouse models offer 
extensive arrays of genetic tools, neither rodent model fully recapitulates essen-
tial aspects of TB lesion progression in man, including granuloma formation and 
maturation10,14.
 The low-cost and high clutch-size zebrafish (D. rerio) is, at the embryonal 
and larval stages, optically transparent, permitting visualization of pathogens and 
lesions in real time15, as well as offering exciting possibilities for high-throughput 
imaging16. Zebrafish are also amenable to forward genetic screening, or reverse 
genetics techniques such as injection of morpholinos (inhibitory of mRNA trans-
lation)17,18. As ectotherm, the zebrafish is one of the natural hosts of M. mari-
num, the closest relative of the M. tuberculosis complex19. Of crucial relevance, 
as shown by the pioneering work of the Ramakrishnan group, M. marinum infec-
tion of zebrafish closely mimics the mammalian TB pattern of infection, both in 
terms of bacterial numbers which increase rapidly in early infection, and of the 
formation of caseous granulomas which present characteristics typical of their 
human counterparts20 - 23.
 The indirect study of human TB via the infection of the zebrafish embryo with 
M. marinum has already led to the clarification of many important processes in 
the life cycle of the infection, in particular those underlying the mechanisms of 
granuloma formation22 - 27. The importance of studying mycobacterial infections at 
a whole organism level was highlighted in the report that induction of mmp9 ex-
pression, enhancing macrophage recruitment to granulomas, was localized to epi-
thelial cells near infected macrophages26. Another example of the use of zebrafish 
larvae to uncover a host-pathogen interaction relevant to human mycobacterial 
infection is the recent forward genetic screen by Tobin and Ramakrishnan, who 
mapped a hypersusceptibility mutation to the leukotriene biosynthesis gene, lta4h, 
and showed that heterozygosity at the LTA4H locus correlated with susceptibility of 
Abstract
One-third of the world population is infected with Mycobacterium tuberculosis 
and multi-drug resistant strains are rapidly evolving. The noticeable absence of 
a whole organism high-throughput screening system for studying the progres-
sion of tuberculosis is fast becoming the bottleneck in tuberculosis research. 
We successfully developed such a system using the zebrafish Mycobacterium 
marinum infection model, which is a well-characterized model for tuberculosis 
progression with biomedical significance, mimicking hallmarks of human tuber-
culosis pathology. Importantly, we demonstrate the suitability of our system 
to directly study M. tuberculosis, showing for the first time that the human 
pathogen can propagate in this vertebrate model, resulting in similar early dis-
ease symptoms to those observed upon M. marinum infection. Our system is 
capable of screening for disease progression via robotic yolk injection of early 
embryos and visual flow screening of late-stage larvae. We also show that this 
system can reliably recapitulate the standard caudal vein injection method with 
a throughput level of 2,000 embryos per hour. We additionally demonstrate 
the possibility of studying signal transduction leading to disease progression 
using reverse genetics at high-throughput levels. Importantly, we use reference 
compounds to validate our system in the testing of molecules that prevent 
tuberculosis progression, making it highly suited for investigating novel anti-
tuberculosis compounds in vivo.
Introduction
Tuberculosis (TB) is an ancient chronic disease caused by M. tuberculosis. With 
one-third of the world population infected, the predominant outcome is a latent 
and persistent infection controlled by type I immune responses1 - 4. An important 
characteristic of this infection is the formation of granulomatous lesions, consist-
ing of clusters of infected macrophages and other immune cells5,6. Paradoxically, 
the main purpose of the host macrophages, which M. tuberculosis infects and 
where it persists, is to clear bacterial infection7,8. M. tuberculosis achieves persis-
tent infection through rapid changes in its gene expression profile in order to 
counteract host cell biological and immune processes, such as antigen presenta-
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human populations to both TB and leprosy28. It is therefore clear that the zebrafish 
mycobacterial infection model is quickly becoming an attractive and advantageous 
alternative for analyzing granuloma and disease progression in vivo.
 The common route of infecting zebrafish embryos with M. marinum is the 
labour-intensive and low-throughput injection of the pathogen into the caudal 
vein of the 1 day old embryo23. This method is labour-intensive and generally 
considered to be a low-throughput technique, leading to major bottlenecks in 
drug discovery particularly in times of high-throughput technology. Since infec-
tion by immersion is not an effective alternative, we sought to achieve a reliable 
high-throughput automatic injection system, drastically reducing the man-hour 
requirement while vastly increasing the number of reproducibly infected em-
bryos. Large quantities of similarly-injected/infected embryos would then allow 
testing of sizeable drug libraries for anti-bacterial activity targeting either the 
pathogen or the host itself.
Here we show that the automatic injector we developed provides a powerful 
and reliable high-throughput system for infecting embryos with M. marinum. We 
also show that we can couple the injector to a flow cytometer capable of sorting 
live multicellular organisms (Complex Object Parametric Analyzer and Sorter, 
COPAS) and rapidly test the efficacy of known anti-TB drugs in infected em-
bryos. Finally, and importantly, we demonstrate that this system is ideally suited 
to test proliferation and tissue spreading of the human pathogen, M. tuberculosis.
Results and Discussion
Proof of principle of yolk sac as early-stage embryo injec-
tion site
We first demonstrated that the injection of 20-40 M. marinum colony-forming units 
(CFUs) into the yolk sac of embryos at several early developmental stages (up to the 
1,024-cell stage) precisely mimics the infection obtained with the well-established 
caudal vein injection method. In our set-up, all injections were performed using poly-
vinylpyrrolidone as a polymer-based carrier for the bacteria, which showed several 
benefits: (1) restriction of early bacterial spread into the embryo, precluding devel-
opmental problems arising from the early injection stage; (2) higher concentration 
homogeneity; (3) clear visibility of injected inoculum as a spheroid (Video S1). 
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Figure 4.1 Outcome of M. 
marinum yolk sac injec-
tion of embryos between 
the 16- and the 512-cell 
stage. 
(A) 5 days post-infection 
(dpi) fli1-egfp larva with 
gfp-labelled vasculature 
showing spread of bacteria 
(red) throughout the body 
(scale bar: 250 µm). (B and 
D) Bright-field/fluorescence 
overlay and (C and E) confo-
cal z-stack of red-fluorescent 
bacteria showing activation 
of green-fluorescent gags at 
the (B and C) edge of the 
yolk extension and on the 
(D and E) tail of a 7 day-old 
larva (scale bar: 25 µm). (F 
and H) Bright-field confocal 
plane and (G and I) confocal 
z-stack of red-fluorescent 
bacteria co-localizing with 
green-fluorescent leukocytes 
detected by L-plastin immu-
nostaining (scale bar: 25 µm). 
The lesions caused by the 
granulomas can be clearly 
seen in F and H.
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the immune system in the spreading and proliferation of mycobacteria after yolk in-
jection, we co-injected a morpholino targeting pu.129 and M. marinum at the 1-2 cell 
stage. The results revealed the presence of extracellular M. marinum and increased 
bacterial proliferation in pu.1 morphants (Figure 4.2A and B), consistent with 
previous data demonstrating that macrophages in zebrafish embryos restrict my-
cobacterial growth25. At 2 dpi, we observed cording structures in Pu.1 morphants, 
characteristic of extracellular mycobacteria27,28, in the tail region of infected embry-
os (Figure 4.2C-E). Using a mag49 (macrophage-activated gene)-GFP23 construct 
in mCherry-labelled bacteria, we were able to confirm their extracellular location 
through the lack of mag49-GFP expression, previously shown to be active only after 
phagocytosis by macrophages23 (Figure 4.2C and D).
High-throughput M. Marinum injection and drug screen
We subsequently developed an automatic injector system around the yolk injec-
tion concept (Figure 4.3 and 4.4). All tests performed demonstrated that this 
injector design, capable of 1,024 consecutive injections per run of 30 minutes, 
reproducibly reached a success rate of over 99% (sample in Video S1) and pro-
duced identical results to manual yolk injections of embryos. Importantly, em-
bryos occupied the hemi-spherical wells of the agarose cast (Figure 4.S1) in 
Besides extensive bacterial growth within the yolk, we witnessed frequent formation 
of aggregates of infected cells outside the site of injection, namely in the head, body 
and tail of the larvae at 5 days post-infection (dpi) (Figure 4.1A). These aggregates 
were highly similar to those previously shown to represent initial stages of granu-
loma development23. No adverse developmental effects were seen in any of the con-
ditions tested. Confirmation that yolk M. marinum injection resulted in granuloma 
formation was obtained through GFP-labelled granuloma-activated gene (gag)23 acti-
vation at 7 dpi using an M. marinum strain also expressing mCherry (Figure 4.1B-
E). Additionally, immunohistochemistry using L-plastin showed clear co-localization 
of M. marinum and leukocytes (Figure 4.1F-I). To functionally analyze the role of 
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Figure 4.2 Effect of yolk sac co-injection of Pu.1 morpholino and M. marinum on bac-
terial localization and proliferation within embryos. (A and B) 3 day-old infected mpx-
gfp transgenic embryos (A) with and (B) without Pu.1 morpholino (scale bar: 250 µm). Greater 
numbers of (extracellular) bacteria throughout body of morphant embryo seen in A contrast 
with lower amount of more localized (phagocytosed) bacteria seen in B. Very low number of 
mpx-gfp labelled neutrophils in A confirms Pu.1 morpholino effect. (C) Bright-field/fluorescence 
overlay and (D) confocal z-stack of mag49-GFP/mCherry bacteria in body of 2 dpi embryo (scale 
bar: 25 µm). Red-fluorescent bacteria form a cording structure adjacent to a few cells contain-
ing green-fluorescent (mag49-activated) bacteria. Lack of green fluorescence in cording bacteria 
indicates no phagocytosis by macrophages and extracellularity. (E) Close-up (digital zoom: 5.2) 
of cording structure formed by extracellular bacteria (scale bar: 10 µm; only red channel shown).
Figure 4.3 Pipeline of high-throughput infection of zebrafish embryos and subse-
quent drug testing. (A) After fertilization eggs are harvested, washed and distributed on injec-
tion plate. (B) Appropriate inoculum is injected in early stage embryos (up to 1,024-cell stage). 
(C) Injected embryos are dispensed into appropriate containers and drug screens take place 
between 3 and 6 dpi. (D) Groups of treated and untreated embryos are separately screened 
using COPAS during (when appropriate) and after drug exposure. Detailed optical analyses are 
performed on selected larvae.
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rial treatment for 3 days. At 5 dpi, the average signal per larva in the untreated 
group was approximately 3-fold higher than that of the treated group, and this 
difference was even more pronounced (4-fold) at 6 dpi (Figure 4.5A and 
Table 4.S1). These results attest both to the efficacy of the combinatorial drug 
treatment and to the ability of the COPAS to correctly discriminate treated and 
untreated groups.
 Epifluorescence and bright-field imaging revealed little to no red signal out-
side the yolk region of the treated larvae, which looked healthy and phenotypi-
cally normal. By contrast, untreated embryos displayed varying bacterial loads 
in the head, body and tail regions (Figure 4.5B, C, E and F). Additionally, the 
individual profiles generated by the COPAS correctly indicated whether bacteria 
were present in the body of infected larva (Figure 4.5D and G). L-plastin im-
munostaining further confirmed co-localization of M. marinum and leukocytes in 
the body of the untreated larvae (Figure 4.1F-I).
High-throughput M. tuberculosis injection and drug screen
It is clear that much can be learned about TB from the study of M. marinum 
infections in zebrafish, and the use of this pathogen offers practical advantages 
when compared to M. tuberculosis, such as lower biosafety restrictions and faster 
a centred and reproducible manner, with the cell mass always resting to the 
side. No image recognition was required for the injections, unlike a previously 
reported design that operates at a throughput level of 25 consecutive injections 
per run of 2 minutes30. The choice of agarose as the casting material dramati-
cally reduced light refraction, resulting in a better image during calibration, and 
helped maintain embryos humid and viable.
 To demonstrate the applicability of our system to drug screens, two inde-
pendent large sets of embryos were injected with M. marinum and treated with 
a combination of first-line anti-TB drugs (Rifampicin and Isoniazid). After 3 days, 
immediately prior to the start of the antibiotic treatment, embryos were run 
through the COPAS flow cytometry system to determine the total level of red 
fluorescence, representative of bacterial load. The embryos were subsequently 
split into two randomly groups, whereby one was subjected to the combinato-
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Figure 4.4 Pictures depicting automatic injector system. (A) the automatic injector 
system inside a laminar flow cabinet; (B) the embryo holder, showing the agarose grid within 
the steel support; (C) the embryo-filled grid, demonstrating the highly reproducible alignment 
of the embryos, with the cell mass resting to the side. Although size variation is observed, the 
embryos are always precisely in the centre of each well (the point of calibration for injection).
Figure 4.5 Automatic yolk sac injection of M. marinum and effect of treatment on 
infected larvae. (A) Effect of treatment on bacterial growth (measured by COPAS) in 5 and 6 
day-old fli1-egfp larvae with gfp-labelled vasculature. Blue bars represent treated embryos, red 
bars represent untreated embryos. (B-D) Untreated versus (E-G) treated 5 day-old larvae, de-
picted whole in (B and E) bright-field and (C and F) fluorescent images, and (D and G) profiled 
by COPAS (scale bar: 250 µm). The localization of bacteria (red) in C and F correlates well 
with COPAS profile peaks in D and G, respectively (peaks in the tail region are shown enlarged 
in the inset; arrowheads depict two representative locations).
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L-plastin immunostaining showed leukocytes clustering around infected regions 
throughout the body, suggesting the formation of granuloma-like aggregates sim-
ilar to those observed with M. marinum infections (Figure 4.6B-D). Leukocytes 
in these aggregates showed intracellular fluorescence of M. tuberculosis bacteria 
(Figure 4.6C and D). In addition, we also observed bacterial accumulation in 
cord-like structures characteristic of extracellular growth27,28.
Concluding remarks
Our work has shown that the automatic injector, coupled with COPAS sort-
ing, provides an extremely powerful high-throughput pipeline for infecting and 
analyzing zebrafish embryos and offers a new in-vivo tool for rapidly testing the 
efficacy of large panels of molecules on the propagation of the pathogen studied. 
Gene-disruption tools, such as morpholinos, can be easily integrated into our 
set-up. Moreover, our results clearly demonstrate, for the first time, the po-
tential of using fish larvae to investigate M. tuberculosis directly, and highlight the 
importance of the automatic injector in enabling a high biosafety-level study that 
would otherwise be technically extremely difficult to accomplish. Interestingly, 
we have recently demonstrated the applicability of our robotic injection system 
for the xenotransplantation of human tumour cell lines into zebrafish embryos 
(data not shown), showing its general relevance in the high-throughput study of 
diseases that benefit from the use of whole vertebrate organisms.
Materials and Methods
Automated injection system
A polycarbonate substrate featuring a honeycomb pattern of 1,024 hemi-spher-
ical wells (1.3 mm diameter) was used to create a negative mould in flexible 
polydimethylsyloxane (PDMS, Sylgard 184, Dow Corning) using standard mould-
ing techniques. A 1% agarose gel (Sphaero) was poured onto an agarose-coated 
glass plate and the PDMS mould was pressed to touch the glass. After gelling 
the mould was removed and the grid was placed in a leakage-free steel support 
(sized to a 96-well plate) (Figure 4.4B).
growth rate. That notwithstanding, it was of interest to study the human pathogen, 
M. tuberculosis, directly in zebrafish. Using our system, we overcame all technical 
difficulties of manually injecting a BSL-3 pathogen into zebrafish embryos. Two 
independent sets of embryos were injected with M. tuberculosis, and were split at 3 
dpi into treated (combinatorial Rifampicin and Isoniazid treatment) and untreated 
groups. To support growth of M. tuberculosis, embryos were maintained at a 
higher temperature (34ºC) than in M. marinum infections (28ºC).
 Confocal imaging of fixed infected larvae revealed the presence of M. tuber-
culosis in their bodies after 5 dpi, indicating that the bacteria survived and were 
transported outside the injected area by macrophages, and that zebrafish larvae 
survive exposure to this pathogen (Figure 4.6A). There was a highly significant 
correlation (p=0.0004) between M. tuberculosis presence in the larvae and the 
absence of treatment (Figure 4.S2). Supporting the survival of M. tuberculosis 
in zebrafish, plating of lysates from 5 and 6 dpi larvae resulted in growth of M. 
tuberculosis colonies. Noteworthy, treated larvae did not yield any colonies, im-
plying that the bacteria were eliminated during treatment.
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Figure 4.6 Automatic yolk sac injection of M. tuberculosis and effect of treatment on 
infected larvae. (A) Confocal z-stack (8x2 stitching) of a 6 day-old whole larva (fli1-egfp with 
gfp-labelled vasculature) showing spread of bacteria (red) throughout the body (scale bar: 250 µm). 
(B) Confocal z-stack of red-fluorescent bacteria co-localizing with green-fluorescent leukocytes de-
tected by L-plastin immunostaining (scale bar: 25 µm). (C) Close-up (digital zoom: 4.2) of bacteria-
containing leukocyte depicted in B by straight arrow (scale bar: 10 µm). (D) Close-up (digital zoom: 
4.3) of bacteria-containing leukocyte depicted in B by arrowhead (scale bar: 10 µm).
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The number of CFU in each inoculum was verified by plating out serial dilutions 
and the injected inoculum in triplicate.
Ethics statement
Zebrafish lines (wild-type, albino/fli1-egfp33 and mpx-gfp34) were handled in com-
pliance with the local animal welfare regulations and maintained according to 
standard protocols (zfin.org). The breeding of adult fish was approved by the 
local animal welfare committee (DEC) of the University of Leiden. All protocols 
adhered to the international guidelines specified by the EU Animal Protection 
Directive 86/609/EEC.
Zebrafish infections
Infections including the Pu.1 morpholino29 (1 mM, Gene Tools) were performed 
by yolk injection (1 nl) at the 1-2 cell stage, whereas all other injections of M. 
marinum (20-40 CFUs) or M. tuberculosis (100 CFUs) took place between 16 and 
512 cells. Control embryos were injected with carrier solution.
 After M. marinum infection, embryos were collected in 92x16 mm petri 
dishes (Sarstedt), with a maximum of 100 embryos per dish, and maintained at 
28ºC in egg water. At 3 dpi embryos were analyzed by the COPAS system (see 
below) and randomly split into two equal groups. One group was exposed to a 
combination of 200 μM Rifampicin (Sigma-Aldrich) and 2 mM Isoniazid (Sigma-
Aldrich) for 3 days (exposure to the drugs achieved by adding compounds to 
egg water; antibiotics refreshed once daily) and the other was followed without 
treatment (water refreshed once daily). Uninjected controls were similarly split 
into treated and untreated groups to account for antibiotic effects. At 5 and 6 
dpi, the different larva groups were analyzed by the COPAS system, and the 
bacterial load was assessed by the total red fluorescence detected.
 After M. tuberculosis infection, embryos were collected in tanks containing 1 
litre of egg water with a maximum of 300 embryos per tank, and maintained at 
34ºC. At 3 dpi embryos were randomly split into treated and untreated groups 
as described above. Twenty larvae per group were homogenized at 5 and 6 dpi 
and plated out to assess the number of live bacteria per larva. Batches of 40-100 
larvae per group were fixed at 5 and 6 dpi for optical analyses.
Immunohistochemistry
Larvae were fixed in 4% paraformaldehyde in PBS overnight at 4ºC and immuno-
labeled using the L-plastin antibody as previously described35.
The embryo grid was placed on a motorized stage (MTmot 200x100 MR, 
Märzhäuser) connected to a controller (Tango, Märzhäuser).
A motorized micro-manipulator (Injectman II, Eppendorf) was adjusted to a vertical 
position above the stage, and connected to a pump (Femtojet Express, Eppendorf) 
featuring an external compressor (lubricated compressor, model 3-4, JUN-AIR).
 A firewire camera (DFK41BF02.H, The Imaging Source) equipped with a 
4x macro lens (MR4/O, The Imaging Source) was placed beneath the stage for 
imaging.
 All components were connected to the controlling computer (Ubuntu 
AMD64). A multi-threaded control program was written in Python, using PySeri-
al and wxPython. Coriander software (http://damien.douxchamps.net/ieee1394/
coriander) was used for imaging.
 The camera height was adjusted to focus on the top plane of the agarose grid, 
and a grid calibration was performed.
 The grid was removed for loading with embryos (Figure 4.4C). The injec-
tion needle (pulled borosilicate glass capillary, Harvard Apparatus) was placed in 
the Injectman and moved to the central focal position. The x and y coordinates 
were stored and the needle was elevated to replace the filled grid.
 The injection height was calibrated using the first embryo by moving the 
needle downwards through the chorion until touching the yolk (400 μm above 
injection point).
Bacterial culture and inoculum preparation
M. marinum strain E11 stably expressing mCherry (pSMT3-mCherry vector)31 
was grown as previously described32, in the presence of 50 μg/mL hygromycin. 
Injection inocula were prepared from glycerol stocks (frozen at OD600=0.75) 
by washing three times in sterile 0.05% Tween80/PBS solution (BD Difco), asses-
sing optical density at 600 nm and resuspending in a 2% polyvinylpyrrolidone40 
(PVP40) solution (CalBiochem) in PBS.
 M. marinum Mma20 strains expressing, in addition to mCherry, mag49-GFP 
or gag7-GFP plasmids23 were cultured in medium containing 20 μg/mL kanamy-
cin and 50 μg/mL hygromycin.
 M. tuberculosis strain H37Rv stably expressing mCherry was maintained in 
logarithmic phase at all times in 7H9 medium (BD Difco Middlebrook) contain-
ing 50 μg/mL hygromycin in a BSL-3 laboratory. Prior to injection, optical density 
at 600 nm was assessed, the bacteria were washed three times in sterile water 
and resuspended in 2% PVP40.
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Statistics
The effect of drug treatment on M. marinum mCherry fluorescence in zebrafish 
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by a χ2-test.
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approach is the “hanging drop assay” that was developed to create embryoid 
bodies from ES cells and has also been applied to cancer cell lines to produce 
tumor-like structures5,6. Alternative methods involve mixing of single cell sus-
pensions with a solidifying ECM, resulting in individual cells that eventually form 
spheroids randomly within a 3D ECM structure7, or seeding polymeric scaffolds 
with cell/ECM suspensions2.
 Cell behavior in 3D cultures is controlled by chemical (composition) and phys-
ical (rigidity, cross-linking) properties of the gel. Natural ECM proteins can be 
used such as collagen, fibrinogen, or the laminin-rich matrigel to represent the 
in-vivo ECM composition most relevant to a given cell type. More recently, syn-
thetic polymers have been developed for 3D CS culture environments although 
it remains to be established how well these support a variety of cell behavioral 
outputs, including cell migration8. Collagen type 1 is an abundant polymer in 
ECM in vivo, and it is widely used for 3D cultures. Various physical properties of 
the collagen gel, such as rigidity and pore size modulate stem cell differentiation, 
cancer growth, and cell migration9-11. Cells can use various migration strategies 
in 3D environments, including mesenchymal or amoeboid individual cell migra-
tion modes or collective invasion strategies, depending on properties of the cells 
and of the matrix10. Changes in matrix pore size can force cells to adopt alterna-
tive migration strategies or - if too extreme - pose a barrier to cell migration. 
Importantly, cells can modify the ECM by physical deformation and proteolysis, 
to overcome such barriers12.
 Chemical compound screens as well as RNAi screens for various types of 
cellular functions, including survival, growth, differentiation, and migration are 
mostly performed in 2D culture conditions. Methods to analyze cells in 3D 
based on the hanging-drop assay are labor and time intensive; are limited to 
cell types that are cohesive and aggregate spontaneously; and are prone to high 
variability between experiments due to variation in aggregation and compaction 
time and CS size. Alternative methods in which single cell suspensions are mixed 
with soluble ECM substrates that are subsequently allowed to form a gel are 
relatively easy to perform but also have several major disadvantages: formation 
of CS depends on the ability of a cell type to survive and proliferate as single cells 
in low adhesion conditions for extended periods; CS formation is time consum-
ing; CS show a large variation in size; and CS form at random locations, which is 
disadvantageous for imaging purposes.
 To allow for CS formation that is relatively fast and easy, highly reproducible, 
and overcomes the disadvantages described above we have developed a novel 
Abstract
Cell spheroids (CS) embedded in 3D extracellular matrix (ECM) serve as in vi-
tro mimics for multicellular structures in vivo. Such cultures, started either from 
spontaneous cell aggregates or single cells dispersed in a gel are time consum-
ing, applicable to restricted cell types only, prone to high variation, and do not 
allow CS formation with defined spatial distribution required for high-through-
put imaging. Here, we describe a novel method where cell-polymer suspen-
sions are microinjected as droplets into collagen gels and CS formation occurs 
within hours for a broad range of cell types. We have automated this method 
to produce CS arrays in fixed patterns with defined x-y-z spatial coordinates 
in 96 well plates and applied automated imaging and image analysis algorithms. 
Low intra- and inter-well variation of initial CS size and CS expansion indicates 
excellent reproducibility. Distinct cell migration patterns, including cohesive 
strand-like- and individual cell migration can be visualized and manipulated. A 
proof-of-principle chemical screen is performed identifying compounds that 
affect cancer cell invasion/migration. Finally, we demonstrate applicability to 
freshly isolated mouse and human tumor biopsy material - indicating potential 
for development of personalized cancer treatment strategies.
Introduction
Cells grown under classical 2D culture conditions behave differently from the 
same cell types grown in vivo. In addition to soluble factors produced in the 
in-vivo microenvironment, differences in cell shape, intercellular contacts, and 
connections to ECM have striking effects on gene expression, cell survival, pro-
liferation, differentiation, cytoarchitecture, and migration. Various systems have 
been developed to culture cells within 3D ECM environments, aimed at more 
closely mimicking the in-vivo context1,2. Several of these systems produce 3D 
cell aggregates in which, after compaction, depletion of oxygen, nutrients, and 
growth factors occurs in the core, leading to cell heterogeneity depending on 
the position in the resulting CS3,4. Multistep methods are used in which aggre-
gates are allowed to form spontaneously and, following a compaction phase, 
can subsequently be transferred to a 3D ECM. The best-known example of this 
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method where cell-polymer suspensions are microinjected into multiwell plates 
containing a collagen gel. This method has been automated to produce CS ar-
rays with highly reproducible properties in large quantities in 96 well plates. We 
use this system to visualize distinct 3D migration strategies and regulation of 
those strategies by ECM properties and actomyosin contractility. We demon-
strate applicability in high-throughput screening platforms in a chemical screen 
for compounds that affect breast cancer invasion/migration. Finally, we apply the 
method to cell suspensions derived from fresh tumor biopsies, which opens the 
possibility to test therapeutic strategies on freshly isolated material from indi-
vidual patients.
Results
Development and characterization of the method
To design a protocol that rapidly produces CS with highly reproducible char-
acteristics we developed a novel method based on microinjection. For the mi-
croinjection method we mixed cells with polyvinylpyrrolidone (PVP), which is 
an inert (hydrophilic) water-soluble synthetic polymer, also used as emulsifier, 
food-additive (E1201) and as solubilizing agent for injections13. In our application 
it was used to delay cell sedimentation within the capillary needle. Furthermore, 
in our experience cells rapidly disperse in the absence of PVP while cells injected 
in the presence of PVP remained localized (e.g. trapped by the polymer) at the 
site of injection, allowing time for aggregation and CS formation.
 We first compared our method to the established hanging drop assay 5. Twen-
ty μl drops containing 5x103 GEß1 cells were used to create hanging drops in 
an inverted 10 cm dish (Fig. 5.1a). The time required to form cell aggregates 
was 24h. These cell aggregates were transferred to agarose-coated dishes where 
they formed tightly packed spheroids over a period of 48h. Next, the spheroids 
were embedded in 2.4 mg/mL collagen solution that was subsequently allowed to 
solidify. For microinjection, GEß1 cells were suspended in 2% PVP, loaded into a 
pulled glass needle, and ~80nL droplets containing ~1x104 cells were injected di-
rectly into preformed 2.4 mg/mL collagen gels where they formed tightly packed 
spheroids within 1h (Fig. 5.1a). Microinjection-derived CS at 24h post-injection 
and hanging-drop-derived CS at 96h post initiation (24h in collagen) displayed 
similar cell migration the following days (Fig. 5.1b). Microinjection-derived CS 
Figure 5.1 Characteristics of microinjection-derived speroids. a, Comparison of hanging-
drop and microinjection method for GEß1 cells. b, Migration of GEß1 cells from hanging-drop 
and microinjection-derived spheroids. c, E-cadherin staining in spheroids at indicated timepoints 
post- injection for 4T1 cells. d, Different modes of cell migration from spheroids for indicated 
cell types showing individual (top row) and cohesive strand migration (bottom row). e, Modula-
tion of cell migration modes by alterations in collagen gel network (left and middle) or inter-
fering with cytoskeletal network (right image, ROCK inhibitor, Y-27632). Arrowheads indicate 
cohesive migration strands; arrows indicate individual migrating cells. Scales, 120 μm.
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 were also established from 4T1 mouse breast carcinoma cells where E-cadherin 
staining marked cell-cell contacts within the first day post-injection that were 
maintained for at least 96h (Fig. 5.1c).
 CS derived by microinjection of different cancer- or non-cancerous cell types 
allowed analysis of various distinct motile strategies in 3D (Fig. 5.1d). Cell types 
that do not typically form cell-cell contacts in 2D cell culture (and that are typi-
cally difficult to study in 3D using the hanging-drop-, liquid overlay-, or other 
assays in absence of additives like matrigel14,15) such as MTLn3 and MDA-MB-231 
breast cancer cells and HT1080 fibrosarcoma cells, displayed amoeboid (MTLn3) 
or mesenchymal (HT1080 and MDA-MB-231) movement of individual cells. On 
the other hand, 4T1 breast cancer, PC-3 prostate cancer, and human microvas-
cular endothelial cells (HMEC) that grow as islands in 2D culture, invaded as 
cohesive strands into the collagen matrix.
 ECM rigidity influences cell behavior in 3D and the actin cytoskeleton is be-
lieved to be essential for sensing and responding to such physical ECM proper-
ties12. We used these CS to study the effect of alterations in ECM network com-
position or intracellular cytoskeletal network properties on migration strategies 
in 3D. Lowering ECM rigidity by decreasing collagen concentration from 2.5 to 
0.25 mg/mL or lowering cytoskeletal tension by application of a ROCK inhibitor, 
both caused a switch from cohesive strand invasion to individual cell migration in 
4T1 cells (Fig. 5.1e). This suggests that tension exerted on cell-cell adhesion struc-
tures either from outside or inside the cell is required for cohesive 3D movement.
 Altogether, these results demonstrate that the microinjection method produces 
CS for 3D growth and migration studies rapidly (hours versus days), conveniently 
(one step), with a broad spectrum of cell types including those that are incompat-
ible with previous methods, and displaying a variety of migration patterns.
Method automation
Since this method has the potential to rapidly create CS with high reproducibility 
for large- scale analysis in 3D ECM of cell growth and migration/invasion we set 
up a procedure to automate the CS formation process. For this purpose, a 96 
well plate containing 60 μL collagen gel per well was placed on a motorized stage 
and the glass needle containing the cell/PVP suspension described above was 
placed vertically in a motorized micromanipulator above the stage (Fig. 5.2a). 
After calibration of needle and 96-well plate using camera vision from under the 
stage, a computer script was used to automate the injection process with vari-
ous macros.
Figure 5.2 Automated pro-
duction of spheroid arrays. 
a,  Automated injection sys-
tem (left) and cell/PVP suspen-
sion containing needle during 
injection (right). b, Bottom 
view of multiple wells with 
4T1 spheroid arays 96 hours 
post-injection. Scale, 10mm. 
c, Upper row shows stitched 
brightfield images showing 
spheroid arrays at indicated 
timepoints. Scale, 1 mm. Bot-
tom row shows cell migra-
tion from single bright-field 
images of spheroids marked 
by dashed rectangle in upper 
row. Scale, 100 μm. d, Mean 
and SD for initial spheroid 
size 4h post-injection (black 
bars) and CS migration over 
~4 days determined from out-
line of migration strands (grey 
bars) obtained from all 7 
spheroids /well for indicated 
wells of a 96-well plate.
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With this set up, cell droplets were injected resulting in spheroids of ~300 μm 
diameter (Movie S1). To increase reproducibility, using commercial needles 
reduced needle tip diameter variance and gels were prepared from a single large 
batch of collagen isolated in-house from rat-tail. Various layouts of injection 
patterns were tested. A hexagonal pattern of 19 spheroids spaced at 1.2 mm 
started to show interaction between migration strands of CS at day 4 but a less 
dense hexagon pattern of 7 spheroids at 2 mm spacing provided sufficient spac-
ing for 96h analysis of CS migration (Fig. 5.2b,c). Visual inspection indicated 
reduced CS migration on the most outer rows and columns of each plate, point-
ing to edge effects. We therefore chose to exclude these wells in all further experi-
ments. We determined reproducibility in all other wells and detected no significant 
intra- or inter-well variation in initial CS size (ANOVA, P>0.5) or CS expansion over 
~92h (ANOVA, P>0.5) (Fig. 5.2d).
 These data demonstrate that the microinjection method can be automated to cre-
ate with high reproducibility and predefined x-y-z coordinates CS arrays in 96 well 
plates. Such properties make this protocol ideal for automated imaging strategies.
Application of the method to automated drug screens
A proof of principle drug screen was performed to test the applicability of this 
procedure to automated high-throughput drug screening assays (HTS). 4T1 CS 
were generated and various previously described inhibitors, including AG1478 
(EGFR), PP2 (Src), ML-7 (MLCK), Y-27632 (ROCK), NSC23766 (Rac), SB-
431542 (TGFβR activin-like kinases), AG-82 (EGFR), LY-294002 (PI3K), JSI-124 
(STAT3) were added one hour later at different concentrations (4, 10, 20 μM) 
in duplicate. Effects on cell migration could be clearly observed by DIC imaging 
after 2 and 4 days for ML-7 and JSI-124 (Fig. 5.3a). For automated imaging and 
image analysis protocols, we labeled the actin cytoskeleton at day 4 of all 10 μM-
treatments and controls (Fig. 5.3b). This allowed automated capture of Z-stacks 
that were converted to maximum projection images, thresholded, and used for 
automated multiparameter analysis including Feret’s diameter and circularity.
 Visual inspection and manual assessment of Feret’s diameter from DIC images 
at day 0 and 4 demonstrated that initial CS size, CS expansion, and inhibition 
of invasion by ML-7 and JSI-124 were highly reproducible (Fig. 5.3a,c). Auto-
mated image analysis fitted well with these data showing that ML-7 and JSI-124 
caused significantly reduced Feret’s diameters (p<0.05) (Fig. 5.3d). For JSI-124 
this correlated with increased circularity (p<0.05) in agreement with inhibition 
of invasion and a remaining round CS. The extremely low values observed for 
Figure 5.3 Results from a drug screen performed on 4T1 cells in a 96 well plate.
 a, DIC images showing tumor cell migration in the presence of indicated inhibitors at indicated 
timepoints (scale = 100 μm). b, Top 2 rows, rhodamine-phalloidin staining and thresholding for 
indicated wells at 4 dpi (columns correspond to treatments from a; rows represent duplicates); 
bottom row, zoom in on well D2 (Ctr), D4 (PP2), and D10 (JSI-124). Scale, 1 mm. c, effect of 
indicated inhibitors on CS migration over ~4 days determined from outline of migration strands 
derived from DIC images in a (mean and SEM for 14 spheroids derived from 2 wells is shown). d, 
Quantification of data derived from automated analysis of fluorescent images shown in B (mean 
and SEM for 14 spheroids derived from 2 wells is shown).
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ML-7 (Fig. 5.3d) despite the fact that a CS was observed by DIC (Fig. 5.3a) can 
be explained by ML-7-induced loss of filamentous actin fibers causing reduced 
staining in this particular method. Alternative staining procedures should lead to 
improvement and compatibility with real-time analysis. Nevertheless, the repro-
ducibility of the injection procedure (Fig. 5.2 and 5.3) combined with the simi-
larity between visual inspection and automated imaging (Fig. 5.3c,d), demon-
strates that this automated injection system can be coupled to fully automated 
imaging and image analysis methodology that is accurate and reproducible.
 
Compatibility of the method with primary biopsy material
We determined if this methodology is compatible with freshly isolated biopsy 
material. First, a cell suspension was generated from 4T1-GFP orthotopic breast 
tumors in mice using collagenase- treatment. In contrast to alternative methods, 
the microinjection method circumvents any 2D tissue culture steps, which may 
cause altered cell behavior16-20. Following injection, these cells rapidly formed CS 
from which migration was analyzed after 3 days (Fig. 5.4a). CS were stained for 
actin and DNA and the near complete overlap between actin and GFP staining 
demonstrates that these CS consist mainly of tumor cells.
 Next, cell suspensions were derived by collagenase treatment of freshly iso-
lated human osteosarcoma and chondrosarcoma tissue. Following injection, CS 
readily formed from these human biopsies and survival and migration could be 
studied for up to one week with the two tumor types showing distinct migratory 
behavior (Fig. 5.4b). Osteosarcoma mainly displayed individual amoeboid move-
ment whereas chondrosarcoma showed predominantly individual mesenchymal 
movement. We treated these CS with the range of compounds described above 
at 10 μM starting one day post-injection. Several of the chemical inhibitors effec-
tively inhibited migration of both tumor types (Fig. 5.4b,c). Notably, the ROCK 
inhibitor Y-27632 did not affect mesenchymal movement but caused switching 
from amoeboid to mesenchymal movement in the osteosarcoma cells, in line 
with the described requirement for ROCK activity only in amoeboid single cell 
movement21.
 Taken together, these data indicate that the automated CS injection method-
ology has the potential to be used for drug testing on tumor cells freshly isolated 
from individual patients.
Figure 5.4 Application to tumor biopsies. a, Overview DIC image (left) and zoom in on 
individual spheroid obtained from 4T1-GFP orthotopic mouse breast tumor. Scales, 1 mm (left 
DIC); 500μm (fluorescent images). b, DIC images showing spheroids derived from osteosarcoma 
(top) and chondrosarcoma biopsy (bottom) treated with indicated inhibitors. Scale, 100μm. C, 
effect of 14 indicated inhibitors on CS migration over ~4 days determined from outline of mi-
gration strands derived for DIC images in a (mean and SD 12 spheroids derived from 2 wells 
is shown). d, Schematic overview of high-throughput spheroid screening indicating procedure 
at day 1 (steps 1- 3) and imaging in absence or presence of compounds at days 2-8 (steps 4-6).
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cell types, in agreement with findings from others8,27-30. Hence, it is essential that 
gel formation is standardized and optimized for each cell type. The use of ECM 
proteins such as collagen has some limitation in terms of controlling batch-to-
batch variation. Therefore, stabilization by chemical crosslinking may be applied 
to better control mechanical properties as porosity and mechanical strength. 
A number of different cross-linking agents that react with specific amino acid 
residues on the collagen molecule, synthetic biopolymer scaffolds, and self-as-
sembling synthetic oligopeptide gels are available to address this27,28,31,32.
 We demonstrate that we can automate each step of the procedure, from 
injection of cell suspensions to imaging and image analysis, while maintaining 
reproducibility. Our method not only accelerates and simplifies CS formation 
but by generating up to 7 CS per well at predefined x-y-z coordinates it is 
compatible with fully automated imaging procedures, enhanced data collec-
tion, and robust statistical analysis. We present a small drug screen to demon-
strate such properties. Finally, we show that the method presented here can 
be used for CS formation directly from freshly isolated tumor biopsy material 
without the need of any intermediate culture steps. This eliminates artificial 
traits induced by 2D culture. A fully analyzed CS cancer migration screen in 96 
well plates can be derived from a biopsy within 1 week. This opens the door 
to screening on a patient-by-patient basis for drug sensitivity of tumor cells 
under conditions that may closely mimic the in-vivo pathophysiological situa-
tion. Clinical tests to validate inhibitor effects in CS screens by comparing with 
therapeutic efficacy can be performed without further modifications of the 
presented system. Moreover, expansions of this method can be envisioned in 
which multiple cell types are combined (e.g. cancer cells and cancer-associated 




The following cell lines were obtained from ATCC: MDA-MB-231, MTLn3, PC-
3, HT1080, 4T1, and MAE. GEβ1 was described earlier33. All cell lines were 
cultured under standard cell culture conditions indicated by ATCC or as de-
scribed33 at 37ºC, 5% CO2 in a humidified incubator. Primary mouse tumor cell 
Discussion
Here, we describe a method for generation of 3D CS cultures based on micro-
injection of cell suspensions into premade gels, that has a number of features 
making it highly useful for drug screening applications: compared to previous 
methods it is easy (one step procedure) and fast (minutes instead of days); CS 
are generated with high accuracy at predetermined x-y-z positions in multiwell 
plates; it is applicable to many different cell types irrespective of the ability of 
cells to form spontaneous cell-cell contacts; it shows good intra- and inter-well 
reproducibility with respect to CS size and migration; because of the predefined 
coordinates of each individual CS the method can easily be combined with fully 
automated imaging and image analysis protocols (Fig. 5.4d).
 2D culture conditions are a very poor representation of the environment cells 
encounter in vivo. Besides implications for cell biology studies, this has important 
consequences for the interpretation of genetic - and drug screens22. So far, these 
have mostly been performed on 2D cultures. For the study of tumor cell inva-
sion the Boyden chamber assay (trans-well migration assay) is also commonly 
used. Here, a monolayer of cells migrates through a thin layer of gel to reach 
the bottom of a filter. This particular assay does not resemble cells disassociat-
ing from a solid tumor. For this purpose, CS cultures have been developed that 
provide a pathophysiological context that mimics solid cancer microenviron-
ments. However, these have not been used for large-scale drug screens due to 
the complicated procedures, which negatively affect reproducibility of results 
and lead to higher costs. Reproducibility of CS size is critical for a reliable 3D 
culture platform. Size and compactness of CS will inevitably affect drug penetra-
tion and previous studies have indicated that CS with diameters between 200 
and 500μm are required to develop chemical gradients (e.g. of oxygen, nutrients, 
and catabolites) that may represent conditions found in tumors3,4,23 - 26. Our au-
tomated approach yields spheroids with a diameter of ~300μm, a size that may 
thus represents solid tumor traits.
 We have used collagen-based gels but the same method could be easily 
adapted to studies using alternative 3D matrices. The type and concentration of 
matrix proteins will have considerable influence on scaffold structure, rigidity, 
and porosity, which will impact on cell morphology, survival, proliferation, and 
migration efficiency8,27,28. We find that changing collagen concentrations has a 
major impact on CS cell migration and that optimal conditions differ for distinct 
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A glass-bottom 96 well plate (Greiner) containing 60 μL solidified 2.4 mg/
mL collagen gel per well was placed in a motorized stage (MTmot 200x100 
MR, Märzhäuser) connected to a controller (Tango, Märzhäuser). A motorized 
micro-manipulator (Injectman II, Eppendorf) was positioned above the stage 
and connected to a pump (Femtojet Express, Eppendorf) featuring an external 
compressor (lubricated compressor, model 3-4, JUN-AIR). A firewire camera 
(DFK41BF02.H, The Imaging Source) equipped with an 8x macro lens (MR8/O, 
The Imaging Source) was placed beneath the stage for calibration and imaging. 
All components were connected to the controlling computer (Ubuntu AMD64). 
A multi-threaded control program was written in Python using PySerial and 
wxPython. Coriander software (http://damien.douxchamps.net/ieee1394/cori-
ander) was used for imaging.
 After the program was calibrated for the 96 well plate the camera height 
was adjusted to focus on the bottom of the 96 well plate. The plate was then 
removed for needle calibration: the injection needle was fixed in the Injectman 
and moved, using the Injectman controller, into the center of the image. The 
injection height was set to 200μm above the bottom of the (virtual) plate.
 After the needle was moved up, the plate was placed back in position and the 
upper left well was used for multiple test injections to adjust pump pressure and 
injection time for optimization of the droplet size (~8nL ~ 300μm diameter) us-
ing video inspection. Subsequently, using a pre-defined macro defining x-y coor-
dinates and number of injections per well, all wells were injected with the same 
pressure and injection time.
Microscopy and image analysis
Manually injected CS were monitored daily using a Nikon Eclipse E600 micro-
scope. CS generated by automated injection were used for montage imaging us-
ing a Nikon TE2000 confocal microscope equipped with a Prior stage controlled 
by NIS Element Software and a temperature and CO2-controlled incubator.
 Differential interference contrast (DIC) images were captured using a charged 
coupled device (CCD) camera with NIS software at 10x dry objective. Quanti-
fication of CS invasion area was analyzed from DIC images using ImageJ. The CS 
ellipsoidal area after three days was estimated using the diameter in x and y axis 
(pi*radius-x*radius-y) occupied by cells in the 10x montage image in the mid-
plane of each spheroid and normalizing to the occupied area 1h after injection. 
One-way ANOVA was performed to test the significance of the data. The data 
suspensions were derived from surplus mouse breast tumor material by mincing 
using scalpel and tissue chopper followed by 2-hour collagenase treatment at 
37°C. Human biopsy material was obtained from surplus material from patients 
that were surgically treated for chondrosarcoma or osteosarcoma. Tumor cell 
suspensions were derived from biopsies by 12h collagenase treatment at 37ºC.
Preparation of collagen
Collagen type I solution was obtained from Upstate-Milipore or isolated from 
rat-tail collagen by acid extraction as described previously34. Collagen was di-
luted to indicated working concentrations of ~2.4 mg/mL in PBS containing 1xD-
MEM (stock 10x, Gibco), 44 mM NaHCO3 (stock 440 mM, Merck), 0.1 M Hepes 
(stock 1M, BioSolve).
Hanging drop method
N 5·103 cells in 20 μL droplets were dispensed onto a 10 cm dish that was 
inverted over a dish containing 10 mL DMEM. After 24h, cell aggregates were 
harvested using a Pasteur pipette and transferred into 10 cm dishes coated with 
0.75% agarose submerged in 10mL DMEM. After 48h, spheroids had formed 
and these were embedded into a 2.4 mg/mL collagen solution using a Pasteur 
pipette. Collagen gels were allowed to solidify at 37ºC for 30 min and overlaid 
with DMEM. Cell invasion was recorded for 3 days using an inverted phase con-
trast light microscope (Nikon Eclipse E600).
Cell preparation for injection method
Cell suspensions derived from trypsin-detached adherent cultures or from col-
lagenase-treated biopsies were filtered to remove clumps, centrifuged at 1000 
rpm for 5 minutes, and washed twice with PBS. ~7x106 cells were re-suspended 
in 30 μL PBS containing 2% polyvinylpyrrolidone (PVP; Sigma-Aldrich). The PVP/
cell suspension was loaded into a beveled pulled glass needle (Eppendorf Cus-
tomTip Type III, OD [μm] 60, Front surface 40, Flexibility: rigid).
Manual injection
Cell suspensions in 2% PVP were microinjected (~1x104 cells/droplet) with a mi-
croinjector (20 psi, PV820 Pneumatic PicoPump, World Precision Instruments, 
Inc) into solidified collagen gels in 8 well μslides (IBIDI).
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The final result of a PhD project is the thesis. Next to the thesis, many of the 
results are also shared in journal articles, in conference proceedings and work-
shops. Sometimes results and ideas are published in patent applications. During 
a PhD project most candidates are involved in teaching bachelor and master 
students. Protocols and specific experimental information is archived in lab jour-
nals. Raw experimental data is generally not stored for a long time, and is usually 
not very well documented. Data remaining after the thesis project is completed, 
can be scattered and unorganized. Data recorded during experiments is not 
published and data with a negative result is often discarded or even thrown 
away. Changes in protocols for specific experiments are sometimes published, 
or only available in the lab journals. The content of a lab journal is mostly or-
dered on time, not on topic or experiment. Therefore, it is hard to search in lab 
journals for previous work.
Research groups
The methodologies used in a group are shared and discussed on a regular basis. 
Methodologies are the group’s most valuable assets, as they determine both the 
success rate of experiments and the scientific value of the experimental data. 
Results that can not easily be repeated or reproduced by others gradually loose 
their value. Many factors contribute to modifications in the commonly used 
methods, for example the personal experiences of individual workers, i.e. a per-
sonal way of doing things, improved methods taken from literature or collabora-
tors, and progress in available technology. New methods are not immediately 
adopted and have to convince the research group first and the peer group later. 
A new method usually requires at least one or more cycles of successful use 
before it becomes accepted. Here, experiments which do not work, produce 
negative results or take too much effort, are usually forgotten as soon as a more 
reproducible or easier methodology is established or published. Only people 
with hands-on experience will remember the original pitfalls and points of care 
of abolished methods. Experience mostly determines whether a certain method 
is being applied in a particular area. It is mostly here where negative results don’t 
have any value, and are simply thrown away. A group, mostly professors and/or 
principal investigators, prevent that these experiments are tried again. However, 
as this information is not shared on a larger scale, many researchers in other lab-
oratories will try similar experiments and mostly reach the same conclusion(s). 
This process itself is not without value as perseverence of (PhD) students may 
Abstract
Academic research results are shared digitally since many years, yet there is a 
lack of uniformity in management of research data. Recent advances in social 
media are used to a limited extent in research. Here, we examine the specific 
requirements of information sharing in research, and show how social media 
can help to improve reproducibility, communication and data storage. When 
available, the adoption of a new social media platform to share knowledge can 
have huge impact on our daily research practice.
Introduction
At the start of a scientific project much of the work builds upon previous or similar 
work and ideas. This includes not only literature, protocols and methods, but also 
daily research practice such as writing a lab journal, data handling including filtering 
and analysis, preparing work discussions and/or presentations. Much effort is spent 
on data analysis, interpretation and model building. Research is part of an iterative 
process, where each step is made based on recent results in discussion with a peer 
group and/or collaborators. Unless the collaboration requires it, raw data is usu-
ally kept personal and accessible to experts only. During research work, there is 
a huge accumulation of information. Before managing this information, one has to 
look at the origin and the objective of gathering information. What information is 
important, what is neglected, and what information can be safely thrown away? In 
this chapter some ideas are presented which may lead to better data management 
to make research more efficient and accessible for future PhD students.
Research
Scientific knowledge can originate from personal projects, for example as in a 
PhD project, and/or can be part of larger projects conducted mostly in research 
groups. Both situations have a specific influence on how research knowledge is 
accessible and dissiminated to other (future) researchers. To unravel this influ-
ence, one has to look at how the data is generated and stored for future use.
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data and/or method. When the method is unaltered, different experiments are 
performed to either test multiple different samples, to get different data sets, or 
multiple similar samples to increase the sensitivity of a single dataset2.
 
Research method development
Research is based on a collection of basic procedures that is used over and over. 
The basic procedures which are often called “methods” or “protocols” are not fixed 
but improved to achieve two aims: to compare multiple (different) experiments or 
to increase the sensitivity and/or accuracy of the method. Next to the methods and 
protocols the analysis of results is becoming more and more predominant due to 
the availability of numerous automated, more complex, and faster analysis methods.
 In method development the experimental method or protocol is changed 
(often by only one change at a time) between experiments, to observe the dif-
ferent data outcomes for each method or protocol change, while the sample re-
mains unchanged or changed as little as possible. Note that differences between 
samples affect the reproducibility, not only of the obtained research data, but 
also of the method result (methodology data).
 When part of the experiment is automated, such as the data analysis, the re-
producibility & reliability are affected by the software version and installation. A 
different version of the software might give another result because of rewrites, 
bug fixes, replacement of software libraries and/or hardware modules. For re-
producibility it is pertinent to know exactly what happened with the raw experi-
ment data during processing, and for this reason open source software must 
always be preferred over closed source software. The source code should have 
version numbering, such that the version can be documented, and mentioned in 
the lab journal and/or method section of a publication. Noteworthy, small proj-
ect specific changes in the source should not be forgotten. Source code control 
systems can be used to automate this process.
 We can conclude that there is much repetition in research. Experiments 
should be repeatable, thus when the method is preserved, the data can be re-
used or regenerated. How is method development currently stored and com-
municated through the research community?
Preserving research knowledge
Taken from Figure 6.1, researchers deal with two interdependent data flows, 
the methodology and research data. What happens with these data flows over 
time is depicted in Figure 6.2.
reintroduce methods that were abandoned earlier in a (slightly) modified form. 
Sometimes new materials, improved instruments, alternative methods or ad-
ditional funding make experimental approaches feasible and viable later. A good 
example is the analysis of the samples obtained in the original Miller experiments 
on the creation of aminoacids1.
Research knowledge
A considerable part of research consists of repetition of the same basic proce-
dures inherently required by the necessary reproducibility. When a research pro-
tocol is invented and published, others can reuse the protocol to generate more 
data from different samples, improve the protocol, or use parts of it in other 
protocols for other experiments. Experiments are often performed to find new 
results, each time the generalized form of such scientific experiments is the same. 
This generalized form is illustrated in Figure 6.1. The illustrated ’method result’, 
for example a ’log file’ in scientific computing or a human observation in biological 
or chemical experiments, is used in experiments to validate the data of the experi-
ment. In research, often, many experiments are performed, of which the ’method 
result’ is observed and used as a control measure to further substantiate to the 
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Figure 6.1 An experiment yields two results, the acquired data and method result that together 
determine the validity of the experiment.
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Who has expert knowledge on which protocol? It is of importance that such 
information is not only directly available from within a group, but also within an 
institute, or maybe even worldwide. This information is, in part, preserved by 
group members that write review papers describing the accepted state of the 
art methods, used in a research field. Unfortunately, review papers do in general 
not contain enough detail to reproduce experiments.
Communication in research
To find more information about a scientific topic, protocol or method, the lit-
erature is searched, and articles are ranked according to journal type, and more 
importantly, the number of citations. The citation system is problematic as it is 
slow and inaccurate. Slow, because only after a couple of years an article will 
have received enough citations to be significantly ’better’ than other articles in 
the field. And inaccurate, because the citations usually target only a specific part 
of an article. This makes it difficult and at least time-consuming for the reader to 
find out how many articles cite a specific part of an article, like a method, part of 
a discussion section or result. Citation is an overall property.
Sharing research data
Within science, as well as in other fields, data is organized by many people. Each 
person has his or her own data storage structure based on personal efforts to 
organize, which in part is also dependent on the time a project is running and 
possible reuse of information from other projects. The personal storage structure 
of data per project can be influenced by the active time one spends in a project, 
the number of collaborators, the amount and methods of communication used in 
the project and by project specific properties such as the connection with other 
 The added value of a group specialized in a specific research methodology, is 
the extra information above the horizontal line of thesis and article information. 
As this knowledge is generally not published, one can only learn this from within 
a group. To reproduce or learn a specific method it is therefore best to visit 
the group and do the experiments on location. In that case the complete data 
flow, located on the right side of Figure 6.2 can be studied and understood. 
Still, when returning to your laboratory, or trying to perform the same experi-
ment elsewhere, part of the information (Figure 6.2, left, above the working 
examples), equipment or expertise is still missing. Then, when the experiment is 
not working the first time, the easiest route is to call someone in the laboratory 
visited. Sometimes, in practice, groups exchange this more detailed information 
by exchanging scientists. The complexity of research projects has similarities with 
Lifecycle Knowledge Management in the manufacturing industry, dealing with 
multiple information sources, multiple media, multiple versions and multiple 
communities3.
 The above showed an idealized situation, in a specialized laboratory, fully 
sharing its newly developed methods among the research community. Not every 
group experiences visiting researchers on a regular basis. The ability to preserve 
knowledge in the group is challenging, especially in a small group of specialists. 
Regularly, people leave a group before all knowledge is transferred in sufficient 
detail to the (new) group members. In that case, new people solely rely on the 
theses, lab-journals and knowledge of the PIs. As a PhD student, one could 
ask a group leader: Where is the actual list of well defined working protocols? 
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Figure 6.2 Visualisation of Information flow for (A) methodology development and (B) data 
acquisition.
Figure 6.3 Books ordered using different schemes
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sons given are trust, quote: “I’m just not willing to depend on search alone”, and 
control, quote: “I want to be sure all the files I need are in one place”, as well as 
visibility and understandability of the structure of the data6. In general, humans 
are uncomfortable when handling large dynamic unstructured data.
Metadata
Currently, when working on a project, all project data is accessed via software; 
emails are enclosed by an email program. The files are stored in folders and 
usually synchronized by email. The timeline is in an agenda, some people use 
agenda programs. The people information is hidden in a list in an email program 
or address book. The websites used are stored in a web-browser, and refer-
ences are stored as pdf or word documents, or in a list in a word file describing 
the project. Some images are stored in powerpoint files or word documents. 
Operating systems such as Windows, Linux and Mac-OS X, and many different 
programs on these systems lack the possibility to share the storage structure of 
different types of data together in a flexible, adoptable way. In fact data sharing 
often appears blocked for commercial reasons. As such the ordering problem is 
intensified on the computer, called information fragmentation, caused by reuse 
of a similar structures in multiple tree hierarchies, e.g. in email programs, per-
sonal and shared file systems, address books etc4.
 From a birds-eye perspective, one can look at the data flows of projects between 
people, and see many repetitive schemes. This repetitive use of different communica-
tion methods in research is not yet optimized. The specific properties of scientific 
project data can be used to automate communication methods. For example, take a 
project file, a protocol, or a data file like an image. When a measurement is made, and 
data is added or modified, many people could benefit from this information. Therefore 
such a file, or the added information, should be communicated to other people. Which 
people should be addressed? Currently, these choices are made repetitively, while 
this list of interested people could have been added as metadata to this project file, 
and reused as such. In a sense, references in the scientific literature form a part of the 
metadata associated with an article. Publishers added a suggestion functionality (based 
on keywords assigned by authors), similarly used by google, booksellers and webshops, 
to find other works or articles of interest to the user. For published articles that one 
reads on-line one can already establish a link to the article to get alerted if new people 
(previous) projects and the overall project flow, the project growth, change of 
goals and collaborators. In essence, the data storage structure is personal, but in-
fluenced by available software, collaborators, project specifics and legal constraints 
(for example in medical research). More on information acquisition, creation, stor-
age, maintenance, retrieval, use and distribution of information can be found in the 
article “Personal Information Management” by William Jones4.
 The personal storage structure and strategy is only partially shared with 
other people. This has a clear reason, as sharing things between people often 
creates an ordering problem.
 Every person likes his or her own ordering scheme. Take for example a book-
shelf, as shown in Figure 6.3. Some people like to order books on titles, other 
people like to order books on topics, then there is a possibility to order on au-
thors or date when the book was bought or used. Next to that there are people 
that like to put little pieces of art in a bookshelf or handicrafts bought in the same 
country where the book was bought. Ask a person, unfamiliar with the ordering 
system used, to take out a specific item. Suppose this person succeeded, the next 
step is to ask this same person to put a new item in this bookshelf. Clearly, shar-
ing a bookshelf with multiple people may give rise to conflicts about the preferred 
ordering of objects. Librarians and book shop owners face this on a daily basis 
and spend time in creating and preserving an optimal system for their customers. 
Simple object classification and successful object retrieval are crucial factors that 
determine the success of a storage system.
When working with computers, sharing files or other pieces of information, 
creates a similar problem. A file is like a book and has associated metadata. The 
fuzziness of the metadata and the personal usage of the metadata is the true 
problem at hand. People like to use the hierarchy of a file system, but just like 
the bookshelf case, this putting files in folders creates an ordering problem. The 
ordering in a file tree is even worse as files are not even visible from outside 
a folder. Although the first vertical filing cabinet was available in the end of the 
18th century5, the personal folder system and shared file servers still bear the 
same principle of a single label per folder. One response to ordering problems is 
the creation of search agents like Google desktop or grep and locate (macosx, 
unix, linux). While these search programs are getting smarter and better they 
do not solve the real problem of simultaneously ordering and sharing (large 
amounts of) data. When asked if a folder system can be replaced with a search 
functionality, many reasons pop-up why a folder system is crucial. Primary rea-
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of data storage, such that many people can view and or adjust the data using 
the same methods. When the internet was still at its infancy the benefits of data 
sharing across networks was already clear, as illustrated in Figure 6.4. The 
aim of DICOM was to store all experimental information, the machine settings, 
other metadata and data files belonging to radiology experiments, in a single file, 
which could be communicated over a network. Since then, many different file 
formats and imaging modalities have been added to use DICOM in other medi-
cal measurements. All these changes and additions have been approved by the 
standards committee. Currently, even medical reports are created using the DI-
COM file format to allow for direct links to the imaging data. A similar standard 
does not exist in research and the DICOM approach is not adapted. DICOM is 
considered a file based information sharing system, all information is contained 
in DICOM files, and metadata is directly and uniquely linked to the data. When 
stored on a computer, a program similar to ’desktop search’ can be used to col-
lect all DICOM files and sort and search using the metadata. The standardization 
of this metadata might pose problems when using DICOM for not yet anticipated 
purposes. Although open ’free to use’ field exist, and undocumented metadata 
can be added, it is therefore not certain that someone else will discover and fol-
low the same scheme. When a vendor/producer of DICOM files decides to use 
new undocumented tags and wants to inform other people about this existence, 
he will also write a DICOM conformance statement in which these additional 
tags are explained. So other people can use this information for e.g. searching 
specific information. The tiff file format, used to store image data, also offers a 
“free to use” metadata field, but suffers from the same access problem.
Social Media for Research
After search engine development, it is now the age of social media. Facebook, 
Twitter, YouTube, Flickr, Wikipedia, Hyves (in the Netherlands) and LinkedIn 
offer direct user-user interaction, giving the opportunity to share messages, dis-
cussions, photos, videos, links, or other information with other people. The 
user-user interaction, monitored on social media sites is used to rate changes 
directly and develop the system itself. Many of the features of Facebook were 
added using the direct quality control of the users of the system. Not even the 
business plan was developed before the system became a huge success.
cite the article or the article is corrected. This can be convenient as it brings you in 
contact with work of people that cite a paper that you consider to be interesting.
Example: DICOM
In medicine, the digital imaging and communication is standardized in a file for-
mat and communication protocol called DICOM, developed by the American 
College of Radiology (ACR) and the National Electrical Manufacturers Associa-
tion (NEMA) in 19857. Originally DICOM was developed as a communication 
protocol, now the main purpose of the DICOM is to allow for standardization 
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Figure 6.4 Illustrating the use of the DICOM standard in 1985, taken from page iv of ACR-
NEMA standards publication/ No. 300-1985
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Tags
Tags are keywords associated with data, and are used online to share public 
information with a large amount of people. The popular site Flickr uses tags to 
sort and filter an enormous amount of photos. Users sharing data can choose 
their tags themselves, and other people can add tags resulting in a collaborative 
set of tags. Not all tags are used as much as others and the tags themselves are 
not stored in a predefined structure. To visualize the use of tags, tag-clouds 
can be used, as invented by Flickr co-founder and interaction designer Stewart 
Butterfield, see Figure 6.5. Within a tag cloud, tags are shown as floating enti-
ties, where tags which are used most often are sized in a larger font. Colors are 
sometimes used to make a clear distinction between tags.
 Collaborative tagging has a large impact not only on the use of the stored 
data, but also on the use of the tags themselves8. Sites such as Flickr and Del.
icio.us use tags without giving a structure to the tags, such as in annotation sys-
tems used in biology. As such the tag names are not controlled and the resulting 
tag set is often called a folksonomy9. Tags allow a user to index an item using 
It could be a giant leap in science if method development and research could be 
performed in a similar way, instead of the slow process of writing research pro-
posals, peer review on proposals, finding people to perform the research, doing 
the research, finding references, reporting on the research, submission of an 
article, peer review, changes, acceptance, waiting and publication. It often takes 
many years before a research idea is published in an article. In a “Facebook-
science-world” the research would be discussed while being designed, published 
as the results come in, and the peer review is replaced by the number of views 
and comments plus the attention the research receives while being performed. 
It gives the opportunity for peers to give suggestions even during the data analy-
sis phase. Data can be shared with others to allow for an even better quanti-
fication, or reveal additional hidden information. When such interaction takes 
place, there is also a reason to publish data yielding negative results, as these can 
be used then as references in other publications. All information and data flows 
would ideally be open and accessible.
 To enable use of the links between scientists, research groups, topics, pa-
pers, meetings, protocols, data and equipment, a network storage model has to 
be put up in which the associated metadata can be stored in a natural and easy 
way. Links offer the possibility to order information based on multiple proper-
ties (metadata). It allows users to organize their data in a personal way without 
knowledge of the underlying storage model. Properties associated with files are 
called metadata. Metadata is already used in a filesystem. Properties such as 
ownership, date of modification, file type and size are used to order files. Pro-
grams can have and create their own specific metadata and access is available via 
a graphical user interface (gui). Sometimes, one wishes to have other (additional) 
metadata available, such as date of creation, picture width and height. When files 
are shared more metadata, like annotations, may become available for the users. 
For example the information ‘made for project x’, ‘also used in project y’ and 
‘therefore shared with user a, user b and user c’. As a conclusion we can say that 
metadata can add value to the data if easily accessible, properly used, and main-
tained and that we would like to use as much metadata as is available without 
having to fill in complete forms of properties. To allow better metadata use, the 
virtual layer describing the files should be extended. Social media have extended 
this virtual layer with websites, (phone) applications and search technologies. 
Most information is linked through the use of tags.
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Figure 6.5 Tag cloud of most frequently used tags at flickr, source wikipedia
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scheme quite difficult to use. Therefore another method of using information in 
networks should be invented. This chapter ends with one example which shows 
how tags can be used to share files in a file system.
Example: TagFS
One could translate the network of tags, as shown above to a tree-like structure 
by starting at a given node (root node) and walking the tags (lines), as if descend-
ing into deeper and deeper sub-directories. This is not always straightforward, 
connections forming rings, pose a problem of relation loops, as visible in the 
more complex network on the right side. Still, if we would allow reuse of the 
identical nodes in the same tree (but not in a single path), from any network 
topography, a tree structure of a network can be constructed. This can be seen 
as using the same image in multiple documents on your computer, or using the 
same documents in different folders without having to copy them (using links, 
also used in some backup/version systems to prevent the storage of multiple 
copies of the same data). Such a tree more closely suits the common use of files 
and other information in projects.
 The tag translated tree differs from a common tree in the file browser, in the 
sense that is does not hide the enclosed information, but filters all information 
according to the enclosed folder names (hence, the transparency mentioned 
above). As such this browsing behavior is already used for public information on 
the internet, in the form of Tags. Selecting multiple tags fits the same behavior as 
to search for files, the autocompletion function in search engines basically show 
indexed tags. Note that a prototype tag based file system, containing some of 
the ideas presented in this chapter, was developed11, but due to inefficiency of 
the code, the project has come to a standstill.
How can networks be used to define rela-
tions, data and metadata in a natural way?
When sharing is added, the network representation allows for a one to one 
visualization of relations between people and how documents in projects are 
used, see Figure 6.7.
multiple keywords. This is optimal when sharing items with a large number of 
people, as everyone can add keywords to index the particular item in his or her 
own index scheme. The advantage of tags with respect to folders is put forward 
by William Jones as follows: 
“If folders become more “transparent” or more like tags, we might be more inclined 
to reference than to copy and more inclined to tag an item in several ways in order to 
represent different anticipated uses” 4
Document sharing can be seen as a certain type of relation in a network. For 
example, some nodes could be persons, and some documents, linked together 
by edges (tags). Sharing a document in a network visualization could then be ex-
plained as walking from node to node to a file, where different routes (tags) could 
lead towards the same object. In Wikipedia, one can “walk” from one document 
to the next by using WikiWords, special words used as tags to Wikipedia articles. 
Through the history section of an article, one can also jump to the wikipage of one 
of the authors, where links to other Wikipedia articles are present.
 Using these networks as an interface could be done by creating a menu from 
the picture of a network as shown in Figure 6.6, for example like the Visual 
Thesaurus Online10. It allows easy viewing. But to use, say to select a couple of 
nodes, or to express more information than just words or colors makes this 
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Figure 6.6 Two different visualizations of scale-free networks, source: www-news.uchicago.edu 
and pmj.bmj.com
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- What’s new? Standing in the root folder of your personal tree, all data can be 
sorted on date, showing the newest item on top immediately, also if added and 
shared by a collaborator. 
- Show all meetings - Agenda items could be indexed using the same tags, then all 
agenda items can be listed from the root folder to list all meetings of all projects. 
- Email all users - Applications like an email application can use the same tree hierar-
chy. Email all users including users in subgroups allows for a natural way of creating a 
list of recipients without having to make a new mailing-list for each project.
Concluding remarks
There is currently no standard for complete data storage and retrieval in research. 
This not only leads to loss of valuable data and knowledge, it also does not prevent 
researchers from doing the same experiments. Research data is not easily con-
tained and documented, as it is usually scattered and unorganized as projects grow 
and shrink, people join and leave, and (analysis)software is updated or replaced. 
Data and developed methods are considered as very personal properties, this may 
be used in future data sharing solutions, i.e. storing the link between data and peo-
ple. Sharing data and methods in research will have many advantages, it allows for 
better reproduction, and saves time if protocols and comments are shared more 
openly. A simple sharing system is not easily developed, and much can be learned 
from current developments on the internet where more and more information is 
shared. Tag based sharing allows for freedom to order and retrieve information, 
while folders and hierarchy can be used to reduce the visible information. A com-
bination of the two might be possible using a tag based file system.
 As digital logbooks emerge and huge databases for data storage are set-up, social 
network sites grow, now seems the right time to find a better solution, such that 
future research is not lost, and a complete history of experimentation in the search 
of new knowledge is preserved and shared globally. This is not only a technical 
challenge, also users should be willing to share their methods. Then, a typical labo-
ratories can form a community on the web, enabling other laboratory to follow the 
activities and comments on the results on a daily base like is done e.g. on Facebook 
when someone publishes a new picture and other people can say that they like it.
A file “article on Y2H” is stored in a different (local) folder structure by Maxim 
(A) and Mathieu (B). When sharing this document, the local folder names could 
be translated to tags (C), giving both users the opportunity to find this document 
by selecting two of the three tags, instead of selecting two (sub)folders. This al-
lows for a personal storage structure without the need to negotiate about the 
optimal (shared) storage tree.
 Key point is that everyone is allowed to use their own preferred ordering of 
data, by walking the network of tags. While the starting position is different, when 
two people share a document, both can access it in exactly the same way, because 
the tags shared are identical as they are shared through the shared document.
Other advantages of a tag based file system
When working with files in a file system it is very inconvenient that files are only 
visible when a certain folder is visited. Often, especially during a search (query) 
operation one likes to view all files in all folders, and then sort them based on 
their content or properties. In an indexed tag system it is very easy to show 
all files including subfolders as this is only one query. This possibility enables a 
smarter use of folders not only for viewing but for applications as well, possibly 
eliminating information fragmentation as was mentioned earlier. Here, some 
examples are presented to show the advantages of such a system: 
Figure 6.7 Tags vs Folders: A file “article on Y2H” is stored in a different (local) folder structure 
by Maxim(A) and Mathieu(B). When sharing this document, the local folder names could be 
translated to tags(C), giving both users the opportunity to find this document by selecting two of 
the three tags, instead of selecting two (sub)folders. This allows for a personal storage structure 
without the need to negotiate about the optimal (shared) storage tree.
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In organisms, tubular cells in the kidney are exposed to laminar flow, but are dif-
ficult to image and study. In standard cell culture there is no flow, and therefore 
the phenotype of these cells in culture is different. When cultured inside micro-
fluidic channels, adherent cells can be subjected to a laminar flow which induces a 
physical shear stress in the cells. A microfluidic chip featuring multiple channels is 
used to study the effect of shear stress on the cell’s phenotype, which is shown to 
change drastically upon shear stress stimulation, as compared to a no-flow control 
on the same chip. It is found, in chapter 2, that tubular cells do not align with the 
flow direction, as is the case with endothelial cells, but do show enhanced motility 
associated first lamellipodia formation and actin stress fibres formation together 
with a reinforcement of the cortical ring. The developed microfluidic chip does 
not need extensive support equipment, fits in a small confined climate chamber 
and is suitable for various light microscopy techniques in combination with high 
resolution imaging.
Microparticles are found in blood plasma, urine, and most other body fluids of 
organisms. These particles have been associated with various diseases as cardio-
vascular diseases, systemic inflammatory disease, thrombosis, and cancer. Detec-
tion and quantification of blood microparticles is difficult because of their small 
size and relatively low abundance in blood. Atomic Force Microscopy (AFM) can 
be used to characterize blood plasma microparticles captured on an antibody 
coated mica surface. In Chapter 3 a specific subset of microparticles is captured 
directly from blood plasma. The plasma is diluted, and subsequently rinsed over 
a small surface area using a microfluidic channel. After detachment of the micro-
fluidic channel, “wet imaging” using AFM is used for high resolution imaging. It 
is demonstrated that high-speed centrifugation has no effect on the qualitative 
Regulatory processes are responsible for the organization, division and death of 
cells in multicellular organisms such as humans. Additionally, cells are highly regu-
lated internally, able to survive and respond in vastly different micro-environments. 
Many types of interactions of cells with their environment can be distinguished, 
and need to be controlled in experiments aimed at unravelling and predicting cel-
lular behavior in vivo. The in-vivo microenvironment is mimicked by exposing cells 
to complex and changing environments. To describe the stochastic differences be-
tween cells and the local experimental conditions in sufficient detail and to obtain 
statistically relevant results, high-throughput experimentation is required. In this 
thesis four new research methods are developed, aimed at a deeper understand-
ing of cellular regulation in vivo. The different aspects of cell biology are adressed 
and introduced in the first chapter.
A general interest in cell biology and interaction with many different people 
were the driving forces in this thesis work. In the Cell Observatory, different 
groups jointly focus on studying cellular processes down to molecular detail, 
share lab spaces, and stimulate interaction between scientists. The complexity 
of biological material requires open discussions between biologists, chemists, 
physicists and engineers to establish a high level of fundamental research and a 
shared experimental design of complex experiments. A common design meth-
odology is proposed to lower language barriers between people from different 
fields, a short introduction is given in the appendix of chapter 1.
Reinventing microinjection
In this thesis, there is a technical overlap between the methods used. Microin-
jection is applied in different settings revealing new possibilities. An overview 
of these approaches is given in Figure 7.1. Taken from a tool off the shelf, mi-
croinjection is commonly perceived as difficult to use. Most applications such as 
cell or zebrafish injection require extensive training, and often obtained results 
differ from person to person. The integration of microinjection in the developed 
methods overcomes most of these difficulties, and demonstrates improved re-
producibility, higher throughput and new research possibilities. For the innova-
tions shown in the grey boxes, four patent applications have been written, which 
can be downloaded from Espacenet (EP1970121, EP2202522, UK1004629.0, 
UK1105226.3) after publication. The applications shown on the bottom row of 
Figure 7.1 are described in chapters 2-5 and summarized below.
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Figure 7.1 Schematic overview of developed applications using microinjection
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addition, spheroids can be created from primary cells directly without interme-
diate culture steps, offering the ability to study responses to various drugs on 
patients own cells. In chapter 5 it is shown how such a screen can be performed 
and can possibly lead to targetted personalized drug medication within 10 days 
in future applications.
The above research projects were all performed in collaborative projects com-
prising eight groups in total, from four research institutes. Data and knowledge 
sharing was sometimes difficult and organized storage of the results, accessible for 
future use and sharing is not yet in place. In chapter 6 the needs and opportunities 
in data management are described in more detail. Hopefully this chapter may lead 
to better data management to make research more efficient and accessible for 
future scientists.
shape of the size distribution, and that AFM imaging allows for detailed quanti-
fication of both size and number of microparticles in a low throughput setup. 
Bacterial infections of organisms can lead to life threatening diseases. Mycobacte-
rium tuberculosis has infected about a third of the world population. Treatment 
is becoming more difficult as multi-drug-resistant strains are evolving. To study 
tuberculosis progression in organisms, a whole organism screening system is 
developed using the zebrafish Mycobacterium marinum infection model, which 
mimics many hallmarks of human tuberculosis pathology. A grid of hemispherical 
holes made in agarose gel is created to align the zebrafish eggs. This allowed for 
the automation of the injection of zebrafish eggs with bacteria up to a through-
put of 2,000 eggs per hour with a 99 percent success rate.
 In chapter 4, the whole embryo screening system is validated using reference 
compounds that prevent tuberculosis progression, making it highly suited for in-
vestigating novel antituberculosis compounds in vivo. The automation of the injec-
tion process allows usage in a BSL3 lab, where the human pathogen M. tuberculo-
sis can be studied safely. For the first time, it is shown that zebrafish can be used 
to directly study infection and propagation of M. tuberculosis, where similar early 
disease symptoms were observed as found after M. marinum infection.
The extracellular matrix (ECM) forms the contact between cells in tissues. Hy-
drogel composed of the same or similar polymers are often used as ECM in 
cell-tissue studies. An aggregate of cancer cells embedded in a hydrogel is a well 
established in vitro cancer tumor model, mimicking in-vivo gradients of oxygen, 
nutrients, small molecules and drugs. In this method, first spheroids were cre-
ated from cells that were stimulated to form cell-cell contacts, and subsequently 
the spheroids are embedded into hydrogel to study of cell migration and sur-
vival processes in different conditions. It is demonstrated in chapter 5 that mi-
croinjection of a cell-polymer suspension in collagen gel can be used to create 
similar spheroids immediately, reducing this spheroid formation time from days 
to minutes. Being dependent on physical rather than biological processes, this 
method of creating cellular spheroids is cell independent, and can be used for 
many cell types. The injected droplets of cells form ‘cellular spheroids’ in which 
cells form cell-cell contacts during the first day. After two days or more, cells 
start to migrate outwards, where the migration speed depends on the collagen 
density and cell-type. Using this method, reproducibly, spheroids are formed at 








op het moment publiek beschikbaar zijn via espacenet (EP1970121, EP2202522) 
of beschikbaar zullen komen (UK1004629.0, UK1105226.3).
Vloeistofstroming
In organen, zoals de nier, worden bepaalde cellen (tubular cells) blootgesteld 
aan vloeistofstromen. In het levende organisme zijn deze cellen moeilijk in detail 
te bestuderen. In celkweek is stroming afwezig en daardoor wijkt het fenotype 
van deze cellen af. Niercellen zijn in speciale microkanalen blootgesteld aan een 
vloeistofstroom, waardoor zij in een natuurlijkere omgeving bestudeerd konden 
worden. In hoofdstuk 2 is het effect van stroming op het fenotype van deze cel-
len, in vergelijking met dezelfde situatie zonder stroming, bekeken. Het blijkt 
dat de cellen niet in de richting van de vloeistofstroom bewegen zoals sommige 
epitheelcellen dat doen. De cellen laten wel extra mobiliteit zien en vormen uit-
lopers (lamellipodia) en stressbundels in het actineskelet. Bundels in het actine-
skelet verstevigen de cel door vorming van een ringstructuur (cortical ring). De 
ontworpen celkweekchip kan gebruikt worden in combinatie met apparatuur die 
standaard aanwezig is de meeste celbiologielaboratoria en kan men een gecon-
troleerde omgeving voor de bestudeerde cellen realiseren. De chip is gebruikt 
in verschillende (hoge resolutie) optische microscopiemethoden en is eenvoudig 
te plaatsen in broedstoven.
Microdeeltjes
In bloed komen kleine deeltjes voor die worden gevormd door cellen en/of 
celresten. Deze deeltjes worden geassocieerd met verschillende ziekten zoals 
hart- en vaatziekten, diverse ontstekingsziekten, trombose en kanker. Detectie 
en kwantificatie van deze deeltjes in bloed wordt bemoeilijkt door de grootte en 
hun relatief lage concentratie. Atomaire kracht microscopie (AFM) kan worden 
Zorgvuldig gereguleerde processen zijn noodzakelijk om multicellulaire orga-
nismen zoals de mens te vormen. Deze processen zijn verantwoordelijk voor 
o.a. de structuur, celdeling en celdood van de tienduizenden miljarden cellen. 
Ook binnen de cellen zijn er veel regulerende processen verantwoordelijk voor 
overleving, stabiliteit, groei en respons in verschillende microscopische habitats. 
Interacties van cellen met hun directe omgeving kunnen worden bestudeerd in 
experimenten. Het voorspellende vermogen van deze experimenten, uitgevoerd 
in vitro, hangt af van het vermogen om de cellen bloot te stellen aan een omgeving 
die zo dicht mogelijk de in-vivo habitat benadert. Om het veranderende gedrag 
van cellen als gevolg van verschillende omgevingsfactoren te kunnen bestuderen 
zijn vele experimenten nodig om op basis van statistische argumenten conclusies 
te kunnen trekken. In dit proefschrift zijn vier nieuwe onderzoeksmethoden 
beschreven gericht op het beter begrijpen van celregulatie in vivo. De verschil-
lende biologische onderzoeksgebieden waar deze methoden toegepast kunnen 
worden zijn kort beschreven in het inleidende hoofdstuk.
 Interesse voor celbiologie en interactie met vele collega’s vormden de drij-
vende kracht in het beschreven onderzoek. In het Cell Observatory werken 
verschillende groepen in gedeelde laboratoriaruimten samen om cellulaire pro-
cessen tot in het moleculaire detail te doorgronden. De complexiteit van de bio-
logie noopt tot open communicatie tussen biologen, chemici, natuurkundigen, 
technici en ingenieurs om fundamenteel onderzoek op hoog niveau mogelijk te 
maken. Om deze communicatie makkelijker te maken is een ontwerpmethode 
gebruikt, geïntroduceerd in het supplement van hoofdstuk één.
Reinventing microinjection
Er is een technologische overlap tussen de methoden die in dit proefschrift 
worden beschreven. Microinjectie is toegepast in verschillende onderzoeksge-
bieden om bestaande methoden te vereenvoudigen en/of om nieuwe toepas-
singen mogelijk te maken. Een overzicht van deze aanpak is schematisch weer-
gegeven in Figuur 8.1. Microinjectie wordt ervaren als ingewikkeld in gebruik. 
Microinjectie toegepast in cellen of proefdieren vereist een gedegen training. 
Ook bij zorgvuldige training blijven de behaalde resultaten vaak verschillen van 
persoon tot persoon. Het is de integratie van microinjectie in de ontwikkelde 
methoden, die het gebruik makkelijker of zelfs mogelijk maken. De beschreven 
experimenten worden beter reproduceerbaar en kunnen bovendien sneller en 
betrouwbaarder uitgevoerd worden. De ontwikkelde methoden zijn beschreven 
in een aantal hoofdstukken en gedetailleerder beschreven in patentaanvragen die 




tuberculosis en Mycobacterium marinum werden vergelijkbare ziekteverschijnselen 
gevonden in de zebravisembryo’s.
Invasieve processen
De extracellulaire matrix (ECM) vormt het contact tussen cellen in weefsels. In 
weefselonderzoek wordt gebruik gemaakt van hydrogel, met dezelfde of ver-
gelijkbare polymeren om de natuurlijke omgeving in weefsels na te bootsen. 
Zo wordt een klompje kankercellen in hydrogel geplaatst om de omgeving van 
tumorweefsel in vitro na te bootsen. Natuurlijke gradiënten van zuurstof, voe-
dingsstoffen, kleine moleculen en eventueel medicijnen komen tot stand door 
een proces als gevolg van diffusie, opname en/of uitstoot van moleculen door 
cellen. Nu worden cellen eerst gestimuleerd om cel-cel contacten te vormen, 
vervolgens worden deze klompjes cellen ingegoten in een gel en tenslotte kun-
nen studies naar overleving en celmigratie uitgevoerd worden. In hoofdstuk 5 
wordt aangetoond dat microinjectie van een mengsel van cellen en polymeren 
direct in een gel uitgevoerd kan worden om klompjes cellen in gel te verkrijgen. 
Hierdoor wordt de voorbereidingstijd verkort van dagen tot enkele minuten. 
Omdat dit proces niet van biologische eigenschappen van cellen afhankelijk is, 
kan het gebruikt worden voor vele celtypen. In het geïnjecteerde mengsel kun-
nen cellen gedurende de eerste dag aan elkaar en aan de gel hechten om zo een 
compact geheel te vormen. Na een dag of twee beginnen sommige typen cellen 
te migreren, op zoek naar voedsel en weg van de afvalstoffen van de naburige 
cellen. De migratiesnelheid hangt af van de gelstructuur en het type cel. Een 
bijkomend voordeel van deze methode is dat de celklompjes op gedefiniëerde 
posities gevormd worden, waardoor ze beter geautomatiseerd bekeken kun-
nen worden. Aangetoond wordt dat de methode toepasbaar is op cellen direct 
afkomstig van kankerweefsel van patiënten (biopten). In de toekomst kan de 
mogelijk voorspellende werking van deze methode op de medicijnrespons van 
individuele patiënten onderzocht worden. In hoofdstuk 5 is te lezen hoe zo’n 
onderzoek kan leiden tot persoonlijk medicijnadvies binnen tien dagen.
Kennisoverdracht
De projecten in dit proefschift werden uitgevoerd in samenwerking met acht 
onderzoeksgroepen, verdeeld over vier onderzoeksinstituten. Het delen van ge-
gevens en kennis in deze projecten was soms moeilijk, en een systeem voor ge-
organiseerde opslag van deze onderzoeksgegevens, toegankelijk voor toekom-
stig gebruik is nog niet beschikbaar. In hoofdstuk 6 wordt dit probleem nader 
gebruikt om deze deeltjes te kwantificeren na binding op een glad mica opper-
vlak. In hoofdstuk 3 worden microdeeltjes direct uit bloedplasma gevangen op 
een mica-oppervlak, dat gecoat is met een antilichaam. Dit gebonden antilichaam 
kan vervolgens specifieke deeltjes uit het bloedplasma invangen. Het na centrifu-
gatie van bloed verkregen plasma wordt verdund en door een klein vloeistofka-
naal over dit actieve oppervlak geleid. Vastgesteld is dat op deze wijze de lokale 
concentratie van de ingevangen deeltjes wordt verhoogd. Doordat het gebruikte 
systeem gedemonteerd kan worden is het mogelijk om het ‘natte’ oppervlak met 
AFM af te tasten. Geautomatiseerde data-analyse laat zien dat centrifugatie op 
hoge snelheid geen invloed heeft op de verdeling van de deeltjesgrootte, en dat 
AFM in combinatie met het vloeistofkanaal een geschikte methode vormt om 
gedetailleerd naar de deeltjesgrootte en deeltjesaantallen te kijken. Door het 
hoge aantal ingevangen deeltjes wordt een verbeterde statistiek verkregen.
Infecties
Bacteriële infecties kunnen levensbedreigende ziekten veroorzaken. Op het mo-
ment van schrijven heeft de bacterie Mycobacterium tuberculosis ongeveer een 
derde van de wereldbevolking besmet. Behandeling van deze infecties wordt 
steeds moeilijker door bacteriële evolutie, resulterend in antibiotica-resistente 
stammen. Om het ziekteproces van tuberculose te bestuderen in organismen 
is een onderzoeksmethode ontwikkeld, gebaseerd op het Mycobacterium ma-
rinum infectiemodel in zebravissen. Deze bacteriële infectie bij zebravissen laat 
overeenkomstige kenmerken zien ten opzichte van de menselijke tuberculose 
variant. Een belangrijk voordeel van het zebravismodel ten opzichte van andere 
diermodellen zoals muizen- of hamstermodellen is dat zebravis embryo’s gro-
tendeels optisch transparant zijn. Hierdoor kunnen ziekteprocessen tot in detail 
bekeken worden in levende organismen. De zebraviseitjes worden bacteriëel 
besmet door de eidooier te injecteren met bacteriën. Deze microinjectie is ge-
automatiseerd door de eitjes in een rooster van agarosegel met daarin halfronde 
kuiltjes te plaatsen. Hierdoor is de plaats van ieder embryo bijna perfect bekend. 
Zo kunnen 2000 eitjes per uur besmet worden met een succespercentage van 
99 procent. In hoofdstuk 4 is deze besmettingsmethode beschreven en toege-
past in een prototype onderzoek om nieuwe medicijnen te vinden. De automa-
tisering van de microinjectie biedt tevens de mogelijkheid om in een BSL3 lab 
te werken, waar ook de humane vorm van tuberculose veilig bestudeerd kan 
worden. Voor de eerste keer is vastgesteld dat ook zebravisembryo’s besmet 




bekeken. Hopelijk leidt deze analyse in de toekomst tot een toegankelijke opslag 
én efficiënter gebruik van kostbare onderzoeksinformatie.
Epiloog
In dit proefschrift zijn voor vier verschillende onderzoeksprojecten nieuwe me-
thoden bedacht, ontwikkeld en gebruikt die hebben geleid tot het verkrijgen van 
nieuwe kennis op het gebied van celbiologie. Belangrijk voor dit onderzoek was 
de directe samenwerking tussen ingenieurs, natuurkundigen, chemici, biofarma-
ceuten, medici en biologen. Als ingenieur uit Delft was het een uitdaging om in 
een niet-technische omgeving te werken, de knelpunten te vinden en op te los-




learning about the ins and outs of patents and IP management, and used it over 
and over again.
Attracted by the academic freedom I was happy to continue as a PhD student, 
many thanks to Leiden University, Jan Pieter and Mathieu for giving me this 
opportunity. I’d like to thank all my colleagues of the Cell Observatory, espe-
cially Jasper, Dilyana, Ellen, Linhua, Henriette, Rhyenne, Wilbert, Backey, Hans 
(2x), Raj, Daniel, Patrick (2x), Rosalie, Igor, Helen, Françoise, Zunfeng, Elisabeth, 
Willem-Jan, RAG, Pavol, Irakli, Maarten and Marta for the very enjoyable time.
I owe a special thanks to Henk, Fred, Emiel, Ewie, Arjen, Tim, Rafael, Jeroen and 
Frits from the department of Fine Mechanics and Co from the department of 
Electronics, not only for their insight, time and effort, but also for their enthusi-
asm during all the different projects and challenges.
Many students were involved in my research. Jos, you were my first student, 
very enthusiastic, and I remember beautiful experiments you performed with 
the dictostelium cells we received from Freek. Esther, thank you for bringing 
the microfluidic cell culture several steps further. Rafael, you came all the way 
from France to work on the automation of the microfluidic connection tech-
nique, thank you for your patience, time and effort. Wendy, you worked on 
many different projects with the aim to get the first usable data from the pro-
totype systems. You took it all with great care and proved to be very valuable 
as researcher and you knew exactly how to write it down, thank you for your 
work, you earned my highest mark with great pride. Kim, you came to me for 
an internship which could not be completed during my PhD, still we took the 
chance to create a novel zebrafish culture plate, thank you for your time and 
effort. Next to internships, many students visited for a short period of experi-
mental work. I’d like to thank Jos, Stein, Dwight, Sander, Pieter, Daan, Frithjof, 
Bartjan, Thomas, Alexi, Teun, Jaap, Robbin, Eva, Silvia, Yingying and Yorrick for 
their enthusiastic work on PDMS, microfluidic chips and Zebrafish.
All the chapters in this thesis describe collaborative projects which were impos-
sible without the many people from the research groups involved. 
 Sylvia, who would have guessed how much patience it required to study cells 
under flow conditions? I’d like to thank you and Hans for your continuous trust 
and support, and Bob for the opportunity to work on this joint project. 
Living as a child in an old farm house, constantly under construction, with lots 
of wood and tools lying around has been a great motivator to start creating. 
For this I’d like to thank my parents, Marja and Leo. Several of the fascinat-
ing projects were boats, the first ones being constructed from cardboard egg-
containers. I was convinced it could support my weight. After I learned about 
the water adsorbing difference between cardboard and wood & styrofoam, my 
sister Daphne had enough faith to test one of my self-constructed boats. I’d like 
to thank my sister, my parents, my grandparents and the rest of my family for 
their love, continuous trust and support.
Dancing and studying in Delft brought a new episode in my life. My housemates 
at Villa67 (Krakeelhof) taught me many lifelong lessons. One being the most 
important is that most of the good things you do in life will always gener-
ate positive and negative responses. Positive thinking means to forget quickly 
about the negative, and to remember and cherish the positive responses. 
 The joy of dancing has been a great distraction during my study, shared with 
many friends. I’d like to thank those with whom I visited many salsa parties 
in my early salsa years: Olivier, Vivian, Andre, Perrie, Nalinie, Nooky, Aartie, 
Monique, Martha, Stuart and Wieske. Especially, I’d like to thank Vivian for 
the great salsa teaching experiences and I hope that we can continue for many 
years. I’d like to thank all of my salsa students for the great fun and enthusiasm, 
especially Melissa, Vicki, Kees-Jan, Maurice, Tal and Rabih for forming the first 
SoSalsa board, and starting a salsa student association in Delft, you made one 
of my dreams come true!
Learning more and more about biology I became amazed by the control and or-
ganisation in cells. It intrigued me that the cytoplasm of cells was more than just 
a soup of proteins, as Mathieu explained to me once during a Cyttron lecture. 
After, I truly loved the freedom to change course as given to me by Jan Pieter 
and Mathieu during my internship, and later again during my PhD project. 
 Hans, thank you for learning me the basics of moulding PDMS and polyure-
thane. Maxim, we truly enjoyed spending many years of research, Amsterdam hu-
mor and solving one problem after another. Without that we wouldn’t have invented 
the microfluidic chip as described in this thesis.  
My first invention, what would it be without the help of Johan and Mark from 
Vereenigde? You taught me not only how to write a patent text, but also how 




Brian, our experiments on blood plasma micro-particles were not perfect, as we 
were continuously searching for the right experimental conditions. I’d like to thank 
you for all the time and effort you put into AFM imaging, the data-analysis and the 
paper. Tjerk, thank you for bringing me and Maxim into this project, you had the 
perfect timing. Yuana, you have laid the groundwork on AFM imaging on micro-
particles, thank you for helping us all along. Susanne and Rogier, thank you for your 
professional advice and experience, I hope the research on micro-particles will con-
tinue and that it will flourish in the future. 
Herman, Ron, somehow I could convince you to invest in a new automated injec-
tion method for zebrafish eggs, which proved to require more innovations than we 
anticipated. Step by step with the help of students and Gabby, followed by Ralph, 
Oliver, Nigel and Wouter we could finally show that zebrafish can be infected with 
Mycobacterium Tuberculosis. Ralph, Oliver, Nigel, Wouter thank you for the joy and 
professionalism during experiments, together we made every experiment count and 
usable for the paper. Nigel, I’ll remember to keep the beer close when you need it. 
 The automated injection system could also be used for cell injections in gel, and I’d 
like Ron and Herman for the opportunity to show this and use the injection system 
for that purpose. That the cell observatory principle works was proven by Sylvia, 
who pointed me to Erik and Hoa, who were microinjecting cells by hand, an applica-
tion ideal for automation, and exactly what I was looking for. Erik, Hoa, thank you 
for the patience, during the setup of the automated injection system. Together we 
created a novel 3D culture method which opens a whole new world of possibilities.
Art, Sebastiaan and Laura, more ideas than could fit in this thesis were discussed 
with you. Thank you for the energy and enthusiasm, let’s hope that many of the 
patents applications will lead to commercial success. David and Timothy from 
Potter Clarkson, thank you for translating most of my ideas into perfect English, 
it was always a thrill to read back the detailed descriptions of the inventions.
For the last chapter on data management I used many comments and tips from 
Albert, Henriette, Erica, Elisabeth, Willem-Jan, Maxim, Jouke, Tal, Kees-Jan, Joke, 
Nora, Zaid, Mathieu, Martine, Alfons and Wieske, thank you so much for con-
tributing.
Working with so many people from so many groups, it is impossible to list ev-
eryone involved. Still I’d like to thank everyone who contributed to this work, 
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